<!DOCTYPE html>

<html>

<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />

<meta name="viewport" content="width=device-width, initial-scale=1" />



<title>Trial Analysis</title>

<script>// Pandoc 2.9 adds attributes on both header and div. We remove the former (to
// be compatible with the behavior of Pandoc < 2.8).
document.addEventListener('DOMContentLoaded', function(e) {
  var hs = document.querySelectorAll("div.section[class*='level'] > :first-child");
  var i, h, a;
  for (i = 0; i < hs.length; i++) {
    h = hs[i];
    if (!/^h[1-6]$/i.test(h.tagName)) continue;  // it should be a header h1-h6
    a = h.attributes;
    while (a.length > 0) h.removeAttribute(a[0].name);
  }
});
</script>
<script>$(document).ready(function(){
    if (typeof $('[data-toggle="tooltip"]').tooltip === 'function') {
        $('[data-toggle="tooltip"]').tooltip();
    }
    if ($('[data-toggle="popover"]').popover === 'function') {
        $('[data-toggle="popover"]').popover();
    }
});
</script>
<style type="text/css">
.lightable-minimal {
border-collapse: separate;
border-spacing: 16px 1px;
width: 100%;
margin-bottom: 10px;
}
.lightable-minimal td {
margin-left: 5px;
margin-right: 5px;
}
.lightable-minimal th {
margin-left: 5px;
margin-right: 5px;
}
.lightable-minimal thead tr:last-child th {
border-bottom: 2px solid #00000050;
empty-cells: hide;
}
.lightable-minimal tbody tr:first-child td {
padding-top: 0.5em;
}
.lightable-minimal.lightable-hover tbody tr:hover {
background-color: #f5f5f5;
}
.lightable-minimal.lightable-striped tbody tr:nth-child(even) {
background-color: #f5f5f5;
}
.lightable-classic {
border-top: 0.16em solid #111111;
border-bottom: 0.16em solid #111111;
width: 100%;
margin-bottom: 10px;
margin: 10px 5px;
}
.lightable-classic tfoot tr td {
border: 0;
}
.lightable-classic tfoot tr:first-child td {
border-top: 0.14em solid #111111;
}
.lightable-classic caption {
color: #222222;
}
.lightable-classic td {
padding-left: 5px;
padding-right: 5px;
color: #222222;
}
.lightable-classic th {
padding-left: 5px;
padding-right: 5px;
font-weight: normal;
color: #222222;
}
.lightable-classic thead tr:last-child th {
border-bottom: 0.10em solid #111111;
}
.lightable-classic.lightable-hover tbody tr:hover {
background-color: #F9EEC1;
}
.lightable-classic.lightable-striped tbody tr:nth-child(even) {
background-color: #f5f5f5;
}
.lightable-classic-2 {
border-top: 3px double #111111;
border-bottom: 3px double #111111;
width: 100%;
margin-bottom: 10px;
}
.lightable-classic-2 tfoot tr td {
border: 0;
}
.lightable-classic-2 tfoot tr:first-child td {
border-top: 3px double #111111;
}
.lightable-classic-2 caption {
color: #222222;
}
.lightable-classic-2 td {
padding-left: 5px;
padding-right: 5px;
color: #222222;
}
.lightable-classic-2 th {
padding-left: 5px;
padding-right: 5px;
font-weight: normal;
color: #222222;
}
.lightable-classic-2 tbody tr:last-child td {
border-bottom: 3px double #111111;
}
.lightable-classic-2 thead tr:last-child th {
border-bottom: 1px solid #111111;
}
.lightable-classic-2.lightable-hover tbody tr:hover {
background-color: #F9EEC1;
}
.lightable-classic-2.lightable-striped tbody tr:nth-child(even) {
background-color: #f5f5f5;
}
.lightable-material {
min-width: 100%;
white-space: nowrap;
table-layout: fixed;
font-family: Roboto, sans-serif;
border: 1px solid #EEE;
border-collapse: collapse;
margin-bottom: 10px;
}
.lightable-material tfoot tr td {
border: 0;
}
.lightable-material tfoot tr:first-child td {
border-top: 1px solid #EEE;
}
.lightable-material th {
height: 56px;
padding-left: 16px;
padding-right: 16px;
}
.lightable-material td {
height: 52px;
padding-left: 16px;
padding-right: 16px;
border-top: 1px solid #eeeeee;
}
.lightable-material.lightable-hover tbody tr:hover {
background-color: #f5f5f5;
}
.lightable-material.lightable-striped tbody tr:nth-child(even) {
background-color: #f5f5f5;
}
.lightable-material.lightable-striped tbody td {
border: 0;
}
.lightable-material.lightable-striped thead tr:last-child th {
border-bottom: 1px solid #ddd;
}
.lightable-material-dark {
min-width: 100%;
white-space: nowrap;
table-layout: fixed;
font-family: Roboto, sans-serif;
border: 1px solid #FFFFFF12;
border-collapse: collapse;
margin-bottom: 10px;
background-color: #363640;
}
.lightable-material-dark tfoot tr td {
border: 0;
}
.lightable-material-dark tfoot tr:first-child td {
border-top: 1px solid #FFFFFF12;
}
.lightable-material-dark th {
height: 56px;
padding-left: 16px;
padding-right: 16px;
color: #FFFFFF60;
}
.lightable-material-dark td {
height: 52px;
padding-left: 16px;
padding-right: 16px;
color: #FFFFFF;
border-top: 1px solid #FFFFFF12;
}
.lightable-material-dark.lightable-hover tbody tr:hover {
background-color: #FFFFFF12;
}
.lightable-material-dark.lightable-striped tbody tr:nth-child(even) {
background-color: #FFFFFF12;
}
.lightable-material-dark.lightable-striped tbody td {
border: 0;
}
.lightable-material-dark.lightable-striped thead tr:last-child th {
border-bottom: 1px solid #FFFFFF12;
}
.lightable-paper {
width: 100%;
margin-bottom: 10px;
color: #444;
}
.lightable-paper tfoot tr td {
border: 0;
}
.lightable-paper tfoot tr:first-child td {
border-top: 1px solid #00000020;
}
.lightable-paper thead tr:last-child th {
color: #666;
vertical-align: bottom;
border-bottom: 1px solid #00000020;
line-height: 1.15em;
padding: 10px 5px;
}
.lightable-paper td {
vertical-align: middle;
border-bottom: 1px solid #00000010;
line-height: 1.15em;
padding: 7px 5px;
}
.lightable-paper.lightable-hover tbody tr:hover {
background-color: #F9EEC1;
}
.lightable-paper.lightable-striped tbody tr:nth-child(even) {
background-color: #00000008;
}
.lightable-paper.lightable-striped tbody td {
border: 0;
}
</style>

<style type="text/css">
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
span.underline{text-decoration: underline;}
div.column{display: inline-block; vertical-align: top; width: 50%;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
</style>



<style type="text/css">
code {
white-space: pre;
}
.sourceCode {
overflow: visible;
}
</style>
<style type="text/css" data-origin="pandoc">
html { -webkit-text-size-adjust: 100%; }
pre > code.sourceCode { white-space: pre; position: relative; }
pre > code.sourceCode > span { display: inline-block; line-height: 1.25; }
pre > code.sourceCode > span:empty { height: 1.2em; }
.sourceCode { overflow: visible; }
code.sourceCode > span { color: inherit; text-decoration: inherit; }
div.sourceCode { margin: 1em 0; }
pre.sourceCode { margin: 0; }
@media screen {
div.sourceCode { overflow: auto; }
}
@media print {
pre > code.sourceCode { white-space: pre-wrap; }
pre > code.sourceCode > span { text-indent: -5em; padding-left: 5em; }
}
pre.numberSource code
{ counter-reset: source-line 0; }
pre.numberSource code > span
{ position: relative; left: -4em; counter-increment: source-line; }
pre.numberSource code > span > a:first-child::before
{ content: counter(source-line);
position: relative; left: -1em; text-align: right; vertical-align: baseline;
border: none; display: inline-block;
-webkit-touch-callout: none; -webkit-user-select: none;
-khtml-user-select: none; -moz-user-select: none;
-ms-user-select: none; user-select: none;
padding: 0 4px; width: 4em;
color: #aaaaaa;
}
pre.numberSource { margin-left: 3em; border-left: 1px solid #aaaaaa; padding-left: 4px; }
div.sourceCode
{ }
@media screen {
pre > code.sourceCode > span > a:first-child::before { text-decoration: underline; }
}
code span.al { color: #ff0000; font-weight: bold; } 
code span.an { color: #60a0b0; font-weight: bold; font-style: italic; } 
code span.at { color: #7d9029; } 
code span.bn { color: #40a070; } 
code span.bu { color: #008000; } 
code span.cf { color: #007020; font-weight: bold; } 
code span.ch { color: #4070a0; } 
code span.cn { color: #880000; } 
code span.co { color: #60a0b0; font-style: italic; } 
code span.cv { color: #60a0b0; font-weight: bold; font-style: italic; } 
code span.do { color: #ba2121; font-style: italic; } 
code span.dt { color: #902000; } 
code span.dv { color: #40a070; } 
code span.er { color: #ff0000; font-weight: bold; } 
code span.ex { } 
code span.fl { color: #40a070; } 
code span.fu { color: #06287e; } 
code span.im { color: #008000; font-weight: bold; } 
code span.in { color: #60a0b0; font-weight: bold; font-style: italic; } 
code span.kw { color: #007020; font-weight: bold; } 
code span.op { color: #666666; } 
code span.ot { color: #007020; } 
code span.pp { color: #bc7a00; } 
code span.sc { color: #4070a0; } 
code span.ss { color: #bb6688; } 
code span.st { color: #4070a0; } 
code span.va { color: #19177c; } 
code span.vs { color: #4070a0; } 
code span.wa { color: #60a0b0; font-weight: bold; font-style: italic; } 
</style>
<script>
// apply pandoc div.sourceCode style to pre.sourceCode instead
(function() {
  var sheets = document.styleSheets;
  for (var i = 0; i < sheets.length; i++) {
    if (sheets[i].ownerNode.dataset["origin"] !== "pandoc") continue;
    try { var rules = sheets[i].cssRules; } catch (e) { continue; }
    var j = 0;
    while (j < rules.length) {
      var rule = rules[j];
      // check if there is a div.sourceCode rule
      if (rule.type !== rule.STYLE_RULE || rule.selectorText !== "div.sourceCode") {
        j++;
        continue;
      }
      var style = rule.style.cssText;
      // check if color or background-color is set
      if (rule.style.color === '' && rule.style.backgroundColor === '') {
        j++;
        continue;
      }
      // replace div.sourceCode by a pre.sourceCode rule
      sheets[i].deleteRule(j);
      sheets[i].insertRule('pre.sourceCode{' + style + '}', j);
    }
  }
})();
</script>



<style type="text/css">

div.csl-bib-body { }
div.csl-entry {
clear: both;
margin-bottom: 0em;
}
.hanging div.csl-entry {
margin-left:2em;
text-indent:-2em;
}
div.csl-left-margin {
min-width:2em;
float:left;
}
div.csl-right-inline {
margin-left:2em;
padding-left:1em;
}
div.csl-indent {
margin-left: 2em;
}
</style>

<style type="text/css">body {
background-color: #fff;
margin: 1em auto;
max-width: 700px;
overflow: visible;
padding-left: 2em;
padding-right: 2em;
font-family: "Open Sans", "Helvetica Neue", Helvetica, Arial, sans-serif;
font-size: 14px;
line-height: 1.35;
}
#TOC {
clear: both;
margin: 0 0 10px 10px;
padding: 4px;
width: 400px;
border: 1px solid #CCCCCC;
border-radius: 5px;
background-color: #f6f6f6;
font-size: 13px;
line-height: 1.3;
}
#TOC .toctitle {
font-weight: bold;
font-size: 15px;
margin-left: 5px;
}
#TOC ul {
padding-left: 40px;
margin-left: -1.5em;
margin-top: 5px;
margin-bottom: 5px;
}
#TOC ul ul {
margin-left: -2em;
}
#TOC li {
line-height: 16px;
}
table {
margin: 1em auto;
border-width: 1px;
border-color: #DDDDDD;
border-style: outset;
border-collapse: collapse;
}
table th {
border-width: 2px;
padding: 5px;
border-style: inset;
}
table td {
border-width: 1px;
border-style: inset;
line-height: 18px;
padding: 5px 5px;
}
table, table th, table td {
border-left-style: none;
border-right-style: none;
}
table thead, table tr.even {
background-color: #f7f7f7;
}
p {
margin: 0.5em 0;
}
blockquote {
background-color: #f6f6f6;
padding: 0.25em 0.75em;
}
hr {
border-style: solid;
border: none;
border-top: 1px solid #777;
margin: 28px 0;
}
dl {
margin-left: 0;
}
dl dd {
margin-bottom: 13px;
margin-left: 13px;
}
dl dt {
font-weight: bold;
}
ul {
margin-top: 0;
}
ul li {
list-style: circle outside;
}
ul ul {
margin-bottom: 0;
}
pre, code {
background-color: #f7f7f7;
border-radius: 3px;
color: #333;
white-space: pre-wrap; 
}
pre {
border-radius: 3px;
margin: 5px 0px 10px 0px;
padding: 10px;
}
pre:not([class]) {
background-color: #f7f7f7;
}
code {
font-family: Consolas, Monaco, 'Courier New', monospace;
font-size: 85%;
}
p > code, li > code {
padding: 2px 0px;
}
div.figure {
text-align: center;
}
img {
background-color: #FFFFFF;
padding: 2px;
border: 1px solid #DDDDDD;
border-radius: 3px;
border: 1px solid #CCCCCC;
margin: 0 5px;
}
h1 {
margin-top: 0;
font-size: 35px;
line-height: 40px;
}
h2 {
border-bottom: 4px solid #f7f7f7;
padding-top: 10px;
padding-bottom: 2px;
font-size: 145%;
}
h3 {
border-bottom: 2px solid #f7f7f7;
padding-top: 10px;
font-size: 120%;
}
h4 {
border-bottom: 1px solid #f7f7f7;
margin-left: 8px;
font-size: 105%;
}
h5, h6 {
border-bottom: 1px solid #ccc;
font-size: 105%;
}
a {
color: #0033dd;
text-decoration: none;
}
a:hover {
color: #6666ff; }
a:visited {
color: #800080; }
a:visited:hover {
color: #BB00BB; }
a[href^="http:"] {
text-decoration: underline; }
a[href^="https:"] {
text-decoration: underline; }

code > span.kw { color: #555; font-weight: bold; } 
code > span.dt { color: #902000; } 
code > span.dv { color: #40a070; } 
code > span.bn { color: #d14; } 
code > span.fl { color: #d14; } 
code > span.ch { color: #d14; } 
code > span.st { color: #d14; } 
code > span.co { color: #888888; font-style: italic; } 
code > span.ot { color: #007020; } 
code > span.al { color: #ff0000; font-weight: bold; } 
code > span.fu { color: #900; font-weight: bold; } 
code > span.er { color: #a61717; background-color: #e3d2d2; } 
</style>




</head>

<body>




<h1 class="title toc-ignore">Trial Analysis</h1>



<pre><code>#&gt; Warning: package &#39;stringr&#39; was built under R version 4.5.2</code></pre>
<div id="introduction" class="section level2">
<h2>Introduction</h2>
<p>This vignette picks up where the previous one (<a href="trial_definition.html">Trial Definition</a>), ends. To recap, our
trial defines the six fundamental elements of a CRM trial as</p>
<div id="the-dose-grid" class="section level4">
<h4>The dose grid</h4>
<p>The trial will use a dose grid consisting of the following doses: 1,
3, 9, 20, 30, 45, 60, 80 and 100. The units in which doses are defined
is irrelevant to the operation of the CRM.</p>
</div>
<div id="the-dose-toxicity-model" class="section level4">
<h4>The dose-toxicity model</h4>
<p>The trial uses a logistic log Normal dose toxicity model</p>
<p><span class="math display">\[ log(\frac{p_i}{1 - p_i}) = \alpha +
\beta log(d_i / d^*) \]</span></p>
<p>where the prior joint distribution of <span class="math inline">\(\alpha\)</span> and <span class="math inline">\(\beta\)</span> is</p>
<p><span class="math display">\[
\begin{bmatrix}
\alpha \\
log(\beta)
\end{bmatrix}   \sim
N\begin{pmatrix}
\begin{bmatrix}
-0.85\\0
\end{bmatrix}   ,
\begin{bmatrix}
1 &amp; -0.5 \\
-0.5 &amp; 1
\end{bmatrix}   
\end{pmatrix}.
\]</span></p>
</div>
<div id="the-increment-rule" class="section level4">
<h4>The increment rule</h4>
<p>The maximum increment for doses greater than <code>0</code> and less
than <code>20</code> is 100 x (1 + 1)%, or 200% of the highest dose used
so far, whereas for <code>20</code> or more, the maximum increment is
100 x (1 + 0.5)%, or 150% of the highest dose used so far.</p>
<p>Note that a 2-fold <em>increment</em> corresponds to a 3-fold
<em>escalation</em>.</p>
</div>
<div id="the-dose-selection-rule" class="section level4">
<h4>The dose selection rule</h4>
<p>Here, we choose to use Neuenschwander’s rule <span class="citation">(Neuenschwander, Branson, and Gsponer 2008)</span>, in
which the dose for the next cohort to be the dose (amongst those doses
that are eligible for selection according to the escalation rule) that
has the highest posterior chance of having a probability of toxicity in
the target range - here [0.2, 0.35) - provided that the dose’s chance of
having a probability in the overdose range - here [0.35, 1.0] - is less
than 0.25.</p>
</div>
<div id="the-cohort-size" class="section level4">
<h4>The cohort size</h4>
<p>Whilst the dose for the next cohort is 20 or less <em>and</em> no
DLTs have been observed, the minimum cohort size is 1. Otherwise, it is
3.</p>
</div>
<div id="the-stopping-rule" class="section level4">
<h4>The stopping rule</h4>
<p>The trial will stop when <i>either</i></p>
<ul>
<li>Twenty patients have been recruited, or.</li>
<li>Both of the following conditions are true
<ul>
<li>At least three cohorts must have been treated AND</li>
<li>The probability that the current estimate of the MTD is in the
target toxicity range must be at least 0.5.</li>
</ul></li>
</ul>
</div>
<div id="trial-definition" class="section level4">
<h4>Trial definition</h4>
<p>The code to define these elements of the trial design is given in the
<a href="trial_definition.Rmd">Trial Definition</a> vignette.</p>
</div>
</div>
<div id="analysing-a-trial" class="section level2">
<h2>Analysing a trial</h2>
<p>Given the trial design constructed above, the process of analysing a
real life instance of the trial is simply a matter of providing the
model with the actual toxicity status of the participants treated so
far. The escalation rules we defined earlier allow the use of a single
patient run-in until either the first DLT is observed or until dose 20
has been administered.</p>
<div id="the-single-patient-run-in" class="section level3">
<h3>The single patient run-in</h3>
<p>Assume that the first three patients - dosed at <code>1</code>,
<code>3</code> and <code>5</code> - completed the trial without
incident, but that the fourth patient - treated at <code>10</code> -
experienced a DLT.</p>
<p>We provide this information to <code>crmPack</code> via a
<code>Data</code> object:</p>
<div class="sourceCode" id="cb2"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb2-1"><a href="#cb2-1" tabindex="-1"></a>firstFour <span class="ot">&lt;-</span> <span class="fu">Data</span>(</span>
<span id="cb2-2"><a href="#cb2-2" tabindex="-1"></a>  <span class="at">x =</span> <span class="fu">c</span>(<span class="dv">1</span>, <span class="dv">3</span>, <span class="dv">9</span>, <span class="dv">20</span>),</span>
<span id="cb2-3"><a href="#cb2-3" tabindex="-1"></a>  <span class="at">y =</span> <span class="fu">c</span>(<span class="dv">0</span>, <span class="dv">0</span>, <span class="dv">0</span>, <span class="dv">1</span>),</span>
<span id="cb2-4"><a href="#cb2-4" tabindex="-1"></a>  <span class="at">ID =</span> <span class="dv">1</span><span class="sc">:</span><span class="dv">4</span>,</span>
<span id="cb2-5"><a href="#cb2-5" tabindex="-1"></a>  <span class="at">cohort =</span> <span class="dv">1</span><span class="sc">:</span><span class="dv">4</span>,</span>
<span id="cb2-6"><a href="#cb2-6" tabindex="-1"></a>  <span class="at">doseGrid =</span> doseGrid</span>
<span id="cb2-7"><a href="#cb2-7" tabindex="-1"></a>)</span></code></pre></div>
<p>Within a <code>Data</code> object, the doses at which each patient is
treated are given by the <code>x</code> slot and their toxicity status
(a Boolean where a toxicity is represented by a truthy value) by the
<code>y</code> slot.</p>
<p>The observed data is easily visualised</p>
<div class="sourceCode" id="cb3"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb3-1"><a href="#cb3-1" tabindex="-1"></a><span class="fu">plot</span>(firstFour)</span></code></pre></div>
<p><img role="img" aria-label="A visual representation of the data from the first four participants.  The first three, treated at doses 1, 3 and 9, do not report any toxicities.  The fourth, treated at 20, does." src="data:image/png;base64,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" alt="A visual representation of the data from the first four participants.  The first three, treated at doses 1, 3 and 9, do not report any toxicities.  The fourth, treated at 20, does." /></p>
<p>and, since the <code>plot</code> method returns a <code>ggplot</code>
object, it is easily customised.</p>
<div class="sourceCode" id="cb4"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb4-1"><a href="#cb4-1" tabindex="-1"></a><span class="fu">plot</span>(firstFour) <span class="sc">+</span> <span class="fu">theme_light</span>()</span></code></pre></div>
<p><img role="img" aria-label="The same graph as above, but with a white background to the plot area rather than a grey one." src="data:image/png;base64,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" alt="The same graph as above, but with a white background to the plot area rather than a grey one." /></p>
<p>Now, update the model to obtain the posterior estimate of the
dose-toxicity curve:</p>
<div class="sourceCode" id="cb5"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb5-1"><a href="#cb5-1" tabindex="-1"></a>vignetteMcmcOptions <span class="ot">&lt;-</span> <span class="fu">McmcOptions</span>(<span class="at">burnin =</span> <span class="dv">100</span>, <span class="at">step =</span> <span class="dv">2</span>, <span class="at">samples =</span> <span class="dv">1000</span>)</span>
<span id="cb5-2"><a href="#cb5-2" tabindex="-1"></a>postSamples <span class="ot">&lt;-</span> <span class="fu">mcmc</span>(</span>
<span id="cb5-3"><a href="#cb5-3" tabindex="-1"></a>  <span class="at">data =</span> firstFour,</span>
<span id="cb5-4"><a href="#cb5-4" tabindex="-1"></a>  <span class="at">model =</span> model,</span>
<span id="cb5-5"><a href="#cb5-5" tabindex="-1"></a>  <span class="at">options =</span> vignetteMcmcOptions</span>
<span id="cb5-6"><a href="#cb5-6" tabindex="-1"></a>)</span></code></pre></div>
<p>The posterior estimate of the dose toxicity curve is easily
visualised:</p>
<div class="sourceCode" id="cb6"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb6-1"><a href="#cb6-1" tabindex="-1"></a><span class="fu">plot</span>(postSamples, model, firstFour)</span></code></pre></div>
<p><img role="img" aria-label="A plot of the posterior after the first four participants.  The mean probability of toxicity increases smoothly, with a slight convex curve, from about zero percent at a dose of zero to about 65% at a dose of 100.  The confidence interval extends from 0% to about 25% at a dose of zero and from about 30% to  about 90% at a dose of 100." src="data:image/png;base64,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" alt="A plot of the posterior after the first four participants.  The mean probability of toxicity increases smoothly, with a slight convex curve, from about zero percent at a dose of zero to about 65% at a dose of 100.  The confidence interval extends from 0% to about 25% at a dose of zero and from about 30% to  about 90% at a dose of 100." /></p>
<p>A visual representation of the model’s state is obtained with:</p>
<div class="sourceCode" id="cb7"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb7-1"><a href="#cb7-1" tabindex="-1"></a><span class="fu">nextBest</span>(</span>
<span id="cb7-2"><a href="#cb7-2" tabindex="-1"></a>  my_next_best,</span>
<span id="cb7-3"><a href="#cb7-3" tabindex="-1"></a>  <span class="at">doselimit =</span> <span class="dv">100</span>,</span>
<span id="cb7-4"><a href="#cb7-4" tabindex="-1"></a>  <span class="at">samples =</span> postSamples,</span>
<span id="cb7-5"><a href="#cb7-5" tabindex="-1"></a>  <span class="at">model =</span> model,</span>
<span id="cb7-6"><a href="#cb7-6" tabindex="-1"></a>  <span class="at">data =</span> empty_data</span>
<span id="cb7-7"><a href="#cb7-7" tabindex="-1"></a>)<span class="sc">$</span>plot</span></code></pre></div>
<p><img role="img" aria-label="Two graphs arranged in a single column.  The upper graph shoes green lines of various heights that show the probability each dose is in the target toxicity range.  There is a big arrow pointing to the bar at a dose of 20, indicating tat this dose has the highest probability of being in the target toxicity range.  The lower graph as a similar series of red lines, indicating the probability that each dose is in the overdose range.  There is a horizontal black dashed line at 25%, indicating that this is the highest acceptable probability of being in the overdose range.  The red bars for doses of 30 and above all extend above 25%, indicating that their toxicity is unacceptable.  The toxicity for doses of 20 and below lie below 25%." src="data:image/png;base64,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" alt="Two graphs arranged in a single column.  The upper graph shoes green lines of various heights that show the probability each dose is in the target toxicity range.  There is a big arrow pointing to the bar at a dose of 20, indicating tat this dose has the highest probability of being in the target toxicity range.  The lower graph as a similar series of red lines, indicating the probability that each dose is in the overdose range.  There is a horizontal black dashed line at 25%, indicating that this is the highest acceptable probability of being in the overdose range.  The red bars for doses of 30 and above all extend above 25%, indicating that their toxicity is unacceptable.  The toxicity for doses of 20 and below lie below 25%." /></p>
<p>The lower panel of the plot shows the posterior probability that each
dose is in the overdose range. The dashed horizontal black line shows
the acceptable risk of overdose: Doses with red lines which go above
this line are considered toxic. The upper panel shows the probability
that each dose is in the target toxicity range. Clearly, doses of
<code>30</code> and <code>45</code> have the highest probability of
being in the target toxicity range. However, the risk that both are in
the overdose range is unacceptable. Therefore, <code>20</code> is the
dose recommended for the next cohort.</p>
<p>We can produce a tabulation of the model state with</p>
<div class="sourceCode" id="cb8"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb8-1"><a href="#cb8-1" tabindex="-1"></a>tabulatePosterior <span class="ot">&lt;-</span> <span class="cf">function</span>(mcmcSamples, observedData) {</span>
<span id="cb8-2"><a href="#cb8-2" tabindex="-1"></a>  <span class="fu">as_tibble</span>(</span>
<span id="cb8-3"><a href="#cb8-3" tabindex="-1"></a>    <span class="fu">nextBest</span>(</span>
<span id="cb8-4"><a href="#cb8-4" tabindex="-1"></a>      my_next_best,</span>
<span id="cb8-5"><a href="#cb8-5" tabindex="-1"></a>      <span class="at">doselimit =</span> <span class="dv">100</span>,</span>
<span id="cb8-6"><a href="#cb8-6" tabindex="-1"></a>      <span class="at">samples =</span> mcmcSamples,</span>
<span id="cb8-7"><a href="#cb8-7" tabindex="-1"></a>      <span class="at">model =</span> model,</span>
<span id="cb8-8"><a href="#cb8-8" tabindex="-1"></a>      <span class="at">data =</span> observedData</span>
<span id="cb8-9"><a href="#cb8-9" tabindex="-1"></a>    )<span class="sc">$</span>probs</span>
<span id="cb8-10"><a href="#cb8-10" tabindex="-1"></a>  ) <span class="sc">%&gt;%</span></span>
<span id="cb8-11"><a href="#cb8-11" tabindex="-1"></a>    <span class="fu">left_join</span>(</span>
<span id="cb8-12"><a href="#cb8-12" tabindex="-1"></a>      <span class="fu">tibble</span>(</span>
<span id="cb8-13"><a href="#cb8-13" tabindex="-1"></a>        <span class="at">dose =</span> observedData<span class="sc">@</span>x,</span>
<span id="cb8-14"><a href="#cb8-14" tabindex="-1"></a>        <span class="at">WithDLT =</span> observedData<span class="sc">@</span>y</span>
<span id="cb8-15"><a href="#cb8-15" tabindex="-1"></a>      ) <span class="sc">%&gt;%</span></span>
<span id="cb8-16"><a href="#cb8-16" tabindex="-1"></a>        <span class="fu">group_by</span>(dose) <span class="sc">%&gt;%</span></span>
<span id="cb8-17"><a href="#cb8-17" tabindex="-1"></a>        <span class="fu">summarise</span>(</span>
<span id="cb8-18"><a href="#cb8-18" tabindex="-1"></a>          <span class="at">Treated =</span> <span class="fu">n</span>(),</span>
<span id="cb8-19"><a href="#cb8-19" tabindex="-1"></a>          <span class="at">WithDLT =</span> <span class="fu">sum</span>(WithDLT),</span>
<span id="cb8-20"><a href="#cb8-20" tabindex="-1"></a>          <span class="at">.groups =</span> <span class="st">&quot;drop&quot;</span></span>
<span id="cb8-21"><a href="#cb8-21" tabindex="-1"></a>        ),</span>
<span id="cb8-22"><a href="#cb8-22" tabindex="-1"></a>      <span class="at">by =</span> <span class="st">&quot;dose&quot;</span></span>
<span id="cb8-23"><a href="#cb8-23" tabindex="-1"></a>    ) <span class="sc">%&gt;%</span></span>
<span id="cb8-24"><a href="#cb8-24" tabindex="-1"></a>    <span class="fu">replace_na</span>(<span class="fu">list</span>(<span class="at">Treated =</span> <span class="dv">0</span>, <span class="at">WithDLT =</span> <span class="dv">0</span>)) <span class="sc">%&gt;%</span></span>
<span id="cb8-25"><a href="#cb8-25" tabindex="-1"></a>    <span class="fu">select</span>(dose, Treated, WithDLT, target, overdose) <span class="sc">%&gt;%</span></span>
<span id="cb8-26"><a href="#cb8-26" tabindex="-1"></a>    kableExtra<span class="sc">::</span><span class="fu">kable</span>(</span>
<span id="cb8-27"><a href="#cb8-27" tabindex="-1"></a>      <span class="at">col.names =</span> <span class="fu">c</span>(<span class="st">&quot;Dose&quot;</span>, <span class="st">&quot;Treated&quot;</span>, <span class="st">&quot;With DLT&quot;</span>, <span class="st">&quot;Target range&quot;</span>, <span class="st">&quot;Overdose range&quot;</span>),</span>
<span id="cb8-28"><a href="#cb8-28" tabindex="-1"></a>      <span class="at">digits =</span> <span class="fu">c</span>(<span class="dv">0</span>, <span class="dv">0</span>, <span class="dv">0</span>, <span class="dv">3</span>, <span class="dv">3</span>)</span>
<span id="cb8-29"><a href="#cb8-29" tabindex="-1"></a>    ) <span class="sc">%&gt;%</span></span>
<span id="cb8-30"><a href="#cb8-30" tabindex="-1"></a>    kableExtra<span class="sc">::</span><span class="fu">add_header_above</span>(<span class="fu">c</span>(<span class="st">&quot; &quot;</span> <span class="ot">=</span> <span class="dv">1</span>, <span class="st">&quot;Participants&quot;</span> <span class="ot">=</span> <span class="dv">2</span>, <span class="st">&quot;Probability that dose is in &quot;</span> <span class="ot">=</span> <span class="dv">2</span>))</span>
<span id="cb8-31"><a href="#cb8-31" tabindex="-1"></a>}</span>
<span id="cb8-32"><a href="#cb8-32" tabindex="-1"></a></span>
<span id="cb8-33"><a href="#cb8-33" tabindex="-1"></a><span class="fu">tabulatePosterior</span>(postSamples, firstFour)</span></code></pre></div>
<table>
<thead>
<tr>
<th style="empty-cells: hide;border-bottom:hidden;" colspan="1">
</th>
<th style="border-bottom:hidden;padding-bottom:0; padding-left:3px;padding-right:3px;text-align: center; " colspan="2">
<div style="border-bottom: 1px solid #ddd; padding-bottom: 5px; ">
Participants
</div>
</th>
<th style="border-bottom:hidden;padding-bottom:0; padding-left:3px;padding-right:3px;text-align: center; " colspan="2">
<div style="border-bottom: 1px solid #ddd; padding-bottom: 5px; ">
Probability that dose is in
</div>
</th>
</tr>
<tr>
<th style="text-align:right;">
Dose
</th>
<th style="text-align:right;">
Treated
</th>
<th style="text-align:right;">
With DLT
</th>
<th style="text-align:right;">
Target range
</th>
<th style="text-align:right;">
Overdose range
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:right;">
1
</td>
<td style="text-align:right;">
1
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0.062
</td>
<td style="text-align:right;">
0.007
</td>
</tr>
<tr>
<td style="text-align:right;">
3
</td>
<td style="text-align:right;">
1
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0.097
</td>
<td style="text-align:right;">
0.031
</td>
</tr>
<tr>
<td style="text-align:right;">
9
</td>
<td style="text-align:right;">
1
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0.202
</td>
<td style="text-align:right;">
0.112
</td>
</tr>
<tr>
<td style="text-align:right;">
20
</td>
<td style="text-align:right;">
1
</td>
<td style="text-align:right;">
1
</td>
<td style="text-align:right;">
0.305
</td>
<td style="text-align:right;">
0.273
</td>
</tr>
<tr>
<td style="text-align:right;">
30
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0.335
</td>
<td style="text-align:right;">
0.430
</td>
</tr>
<tr>
<td style="text-align:right;">
45
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0.244
</td>
<td style="text-align:right;">
0.676
</td>
</tr>
<tr>
<td style="text-align:right;">
60
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0.138
</td>
<td style="text-align:right;">
0.829
</td>
</tr>
<tr>
<td style="text-align:right;">
80
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0.076
</td>
<td style="text-align:right;">
0.912
</td>
</tr>
<tr>
<td style="text-align:right;">
100
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0.051
</td>
<td style="text-align:right;">
0.945
</td>
</tr>
</tbody>
</table>
<p>From these presentations, we can see that:</p>
<ol style="list-style-type: decimal">
<li>The highest dose so far administered is <code>20</code>, so the
escalation rule permits doses up to and including <code>40</code> to be
considered as the dose for the next cohort. However…</li>
<li>Doses of <code>30</code> and above are considered unsafe</li>
<li>Of the remaining doses, <code>20</code> has the highest posterior
probability of being in the target toxicity range</li>
<li>A DLT has been reported</li>
</ol>
<p>Items 1 and 4 in the list tell us both that the size of the next
cohort should be three. Items 2 and 3 together imply that the highest
dose that can be used in the next cohort is <code>20</code>.</p>
<p>Thus, the model’s recommendation is that the next cohort should
consist of three patients, each treated at <code>20</code>. This can be
confirmed programmatically:</p>
<div class="sourceCode" id="cb9"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb9-1"><a href="#cb9-1" tabindex="-1"></a>nextMaxDose <span class="ot">&lt;-</span> <span class="fu">maxDose</span>(my_increments, firstFour)</span>
<span id="cb9-2"><a href="#cb9-2" tabindex="-1"></a>nextMaxDose</span>
<span id="cb9-3"><a href="#cb9-3" tabindex="-1"></a><span class="co">#&gt; [1] 40</span></span>
<span id="cb9-4"><a href="#cb9-4" tabindex="-1"></a></span>
<span id="cb9-5"><a href="#cb9-5" tabindex="-1"></a>doseRecommendation <span class="ot">&lt;-</span> <span class="fu">nextBest</span>(</span>
<span id="cb9-6"><a href="#cb9-6" tabindex="-1"></a>  my_next_best,</span>
<span id="cb9-7"><a href="#cb9-7" tabindex="-1"></a>  <span class="at">doselimit =</span> nextMaxDose,</span>
<span id="cb9-8"><a href="#cb9-8" tabindex="-1"></a>  <span class="at">samples =</span> postSamples,</span>
<span id="cb9-9"><a href="#cb9-9" tabindex="-1"></a>  <span class="at">model =</span> model,</span>
<span id="cb9-10"><a href="#cb9-10" tabindex="-1"></a>  <span class="at">data =</span> firstFour</span>
<span id="cb9-11"><a href="#cb9-11" tabindex="-1"></a>)</span>
<span id="cb9-12"><a href="#cb9-12" tabindex="-1"></a>doseRecommendation<span class="sc">$</span>value</span>
<span id="cb9-13"><a href="#cb9-13" tabindex="-1"></a><span class="co">#&gt; [1] 9</span></span></code></pre></div>
<p>However, given that the probability that <code>20</code> is in the
overdose range is only just less than the threshold of 0.25 (and because
the only participant so far treated at <code>20</code> experienced a
DLT) it would be a perfectly reasonable clinical decision to treat the
next cohort at <code>10</code> - or, indeed, at any other dose below
<code>20</code>. <i>There is absolutely no obligation to follow the CRM
dose recommendation without consideration of other factors that might
affect the choice of the most appropriate dose for the next cohort.</i>
However, for the purpose of exposition, we will treat the next cohort at
<code>20</code>, as recommended by the model.</p>
<p>We can confirm that the trial’s stopping rules have not been
satisfied:</p>
<div class="sourceCode" id="cb10"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb10-1"><a href="#cb10-1" tabindex="-1"></a><span class="fu">stopTrial</span>(</span>
<span id="cb10-2"><a href="#cb10-2" tabindex="-1"></a>  my_stopping,</span>
<span id="cb10-3"><a href="#cb10-3" tabindex="-1"></a>  <span class="at">dose =</span> doseRecommendation<span class="sc">$</span>value,</span>
<span id="cb10-4"><a href="#cb10-4" tabindex="-1"></a>  postSamples,</span>
<span id="cb10-5"><a href="#cb10-5" tabindex="-1"></a>  model,</span>
<span id="cb10-6"><a href="#cb10-6" tabindex="-1"></a>  firstFour</span>
<span id="cb10-7"><a href="#cb10-7" tabindex="-1"></a>)</span>
<span id="cb10-8"><a href="#cb10-8" tabindex="-1"></a><span class="co">#&gt; [1] FALSE</span></span>
<span id="cb10-9"><a href="#cb10-9" tabindex="-1"></a><span class="co">#&gt; attr(,&quot;message&quot;)</span></span>
<span id="cb10-10"><a href="#cb10-10" tabindex="-1"></a><span class="co">#&gt; attr(,&quot;message&quot;)[[1]]</span></span>
<span id="cb10-11"><a href="#cb10-11" tabindex="-1"></a><span class="co">#&gt; attr(,&quot;message&quot;)[[1]][[1]]</span></span>
<span id="cb10-12"><a href="#cb10-12" tabindex="-1"></a><span class="co">#&gt; [1] &quot;Number of cohorts is 4 and thus reached the prespecified minimum number 3&quot;</span></span>
<span id="cb10-13"><a href="#cb10-13" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb10-14"><a href="#cb10-14" tabindex="-1"></a><span class="co">#&gt; attr(,&quot;message&quot;)[[1]][[2]]</span></span>
<span id="cb10-15"><a href="#cb10-15" tabindex="-1"></a><span class="co">#&gt; [1] &quot;Probability for target toxicity is 20 % for dose 9 and thus below the required 50 %&quot;</span></span>
<span id="cb10-16"><a href="#cb10-16" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb10-17"><a href="#cb10-17" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb10-18"><a href="#cb10-18" tabindex="-1"></a><span class="co">#&gt; attr(,&quot;message&quot;)[[2]]</span></span>
<span id="cb10-19"><a href="#cb10-19" tabindex="-1"></a><span class="co">#&gt; [1] &quot;Number of patients is 4 and thus below the prespecified minimum number 20&quot;</span></span>
<span id="cb10-20"><a href="#cb10-20" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb10-21"><a href="#cb10-21" tabindex="-1"></a><span class="co">#&gt; attr(,&quot;individual&quot;)</span></span>
<span id="cb10-22"><a href="#cb10-22" tabindex="-1"></a><span class="co">#&gt; attr(,&quot;individual&quot;)[[1]]</span></span>
<span id="cb10-23"><a href="#cb10-23" tabindex="-1"></a><span class="co">#&gt; [1] FALSE</span></span>
<span id="cb10-24"><a href="#cb10-24" tabindex="-1"></a><span class="co">#&gt; attr(,&quot;message&quot;)</span></span>
<span id="cb10-25"><a href="#cb10-25" tabindex="-1"></a><span class="co">#&gt; attr(,&quot;message&quot;)[[1]]</span></span>
<span id="cb10-26"><a href="#cb10-26" tabindex="-1"></a><span class="co">#&gt; [1] &quot;Number of cohorts is 4 and thus reached the prespecified minimum number 3&quot;</span></span>
<span id="cb10-27"><a href="#cb10-27" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb10-28"><a href="#cb10-28" tabindex="-1"></a><span class="co">#&gt; attr(,&quot;message&quot;)[[2]]</span></span>
<span id="cb10-29"><a href="#cb10-29" tabindex="-1"></a><span class="co">#&gt; [1] &quot;Probability for target toxicity is 20 % for dose 9 and thus below the required 50 %&quot;</span></span>
<span id="cb10-30"><a href="#cb10-30" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb10-31"><a href="#cb10-31" tabindex="-1"></a><span class="co">#&gt; attr(,&quot;individual&quot;)</span></span>
<span id="cb10-32"><a href="#cb10-32" tabindex="-1"></a><span class="co">#&gt; attr(,&quot;individual&quot;)[[1]]</span></span>
<span id="cb10-33"><a href="#cb10-33" tabindex="-1"></a><span class="co">#&gt; [1] TRUE</span></span>
<span id="cb10-34"><a href="#cb10-34" tabindex="-1"></a><span class="co">#&gt; attr(,&quot;message&quot;)</span></span>
<span id="cb10-35"><a href="#cb10-35" tabindex="-1"></a><span class="co">#&gt; [1] &quot;Number of cohorts is 4 and thus reached the prespecified minimum number 3&quot;</span></span>
<span id="cb10-36"><a href="#cb10-36" tabindex="-1"></a><span class="co">#&gt; attr(,&quot;report_label&quot;)</span></span>
<span id="cb10-37"><a href="#cb10-37" tabindex="-1"></a><span class="co">#&gt; [1] &quot;≥ 3 cohorts dosed&quot;</span></span>
<span id="cb10-38"><a href="#cb10-38" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb10-39"><a href="#cb10-39" tabindex="-1"></a><span class="co">#&gt; attr(,&quot;individual&quot;)[[2]]</span></span>
<span id="cb10-40"><a href="#cb10-40" tabindex="-1"></a><span class="co">#&gt; [1] FALSE</span></span>
<span id="cb10-41"><a href="#cb10-41" tabindex="-1"></a><span class="co">#&gt; attr(,&quot;message&quot;)</span></span>
<span id="cb10-42"><a href="#cb10-42" tabindex="-1"></a><span class="co">#&gt; [1] &quot;Probability for target toxicity is 20 % for dose 9 and thus below the required 50 %&quot;</span></span>
<span id="cb10-43"><a href="#cb10-43" tabindex="-1"></a><span class="co">#&gt; attr(,&quot;report_label&quot;)</span></span>
<span id="cb10-44"><a href="#cb10-44" tabindex="-1"></a><span class="co">#&gt; [1] &quot;P(0.2 ≤ prob(DLE | NBD) ≤ 0.35) ≥ 0.5&quot;</span></span>
<span id="cb10-45"><a href="#cb10-45" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb10-46"><a href="#cb10-46" tabindex="-1"></a><span class="co">#&gt; attr(,&quot;report_label&quot;)</span></span>
<span id="cb10-47"><a href="#cb10-47" tabindex="-1"></a><span class="co">#&gt; [1] NA</span></span>
<span id="cb10-48"><a href="#cb10-48" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb10-49"><a href="#cb10-49" tabindex="-1"></a><span class="co">#&gt; attr(,&quot;individual&quot;)[[2]]</span></span>
<span id="cb10-50"><a href="#cb10-50" tabindex="-1"></a><span class="co">#&gt; [1] FALSE</span></span>
<span id="cb10-51"><a href="#cb10-51" tabindex="-1"></a><span class="co">#&gt; attr(,&quot;message&quot;)</span></span>
<span id="cb10-52"><a href="#cb10-52" tabindex="-1"></a><span class="co">#&gt; [1] &quot;Number of patients is 4 and thus below the prespecified minimum number 20&quot;</span></span>
<span id="cb10-53"><a href="#cb10-53" tabindex="-1"></a><span class="co">#&gt; attr(,&quot;report_label&quot;)</span></span>
<span id="cb10-54"><a href="#cb10-54" tabindex="-1"></a><span class="co">#&gt; [1] &quot;≥ 20 patients dosed&quot;</span></span>
<span id="cb10-55"><a href="#cb10-55" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb10-56"><a href="#cb10-56" tabindex="-1"></a><span class="co">#&gt; attr(,&quot;report_label&quot;)</span></span>
<span id="cb10-57"><a href="#cb10-57" tabindex="-1"></a><span class="co">#&gt; [1] NA</span></span></code></pre></div>
</div>
<div id="the-first-full-cohort" class="section level3">
<h3>The first full cohort</h3>
<p>Assume that none of the three patients in the first full cohort
report a DLT:</p>
<div class="sourceCode" id="cb11"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb11-1"><a href="#cb11-1" tabindex="-1"></a>firstFullCohort <span class="ot">&lt;-</span> <span class="fu">Data</span>(</span>
<span id="cb11-2"><a href="#cb11-2" tabindex="-1"></a>  <span class="at">x =</span> <span class="fu">c</span>(<span class="dv">1</span>, <span class="dv">3</span>, <span class="dv">9</span>, <span class="dv">20</span>, <span class="dv">20</span>, <span class="dv">20</span>, <span class="dv">20</span>),</span>
<span id="cb11-3"><a href="#cb11-3" tabindex="-1"></a>  <span class="at">y =</span> <span class="fu">c</span>(<span class="dv">0</span>, <span class="dv">0</span>, <span class="dv">0</span>, <span class="dv">1</span>, <span class="dv">0</span>, <span class="dv">0</span>, <span class="dv">0</span>),</span>
<span id="cb11-4"><a href="#cb11-4" tabindex="-1"></a>  <span class="at">ID =</span> <span class="dv">1</span><span class="sc">:</span><span class="dv">7</span>,</span>
<span id="cb11-5"><a href="#cb11-5" tabindex="-1"></a>  <span class="at">cohort =</span> <span class="fu">c</span>(<span class="dv">1</span><span class="sc">:</span><span class="dv">4</span>, <span class="fu">rep</span>(<span class="dv">5</span>, <span class="dv">3</span>)),</span>
<span id="cb11-6"><a href="#cb11-6" tabindex="-1"></a>  <span class="at">doseGrid =</span> doseGrid</span>
<span id="cb11-7"><a href="#cb11-7" tabindex="-1"></a>)</span></code></pre></div>
<p>Update the model:</p>
<div class="sourceCode" id="cb12"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb12-1"><a href="#cb12-1" tabindex="-1"></a>postSamples1 <span class="ot">&lt;-</span> <span class="fu">mcmc</span>(</span>
<span id="cb12-2"><a href="#cb12-2" tabindex="-1"></a>  <span class="at">data =</span> firstFullCohort,</span>
<span id="cb12-3"><a href="#cb12-3" tabindex="-1"></a>  <span class="at">model =</span> model,</span>
<span id="cb12-4"><a href="#cb12-4" tabindex="-1"></a>  <span class="at">options =</span> vignetteMcmcOptions</span>
<span id="cb12-5"><a href="#cb12-5" tabindex="-1"></a>)</span></code></pre></div>
<p>Tabulate the posterior:</p>
<div class="sourceCode" id="cb13"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb13-1"><a href="#cb13-1" tabindex="-1"></a><span class="fu">tabulatePosterior</span>(postSamples1, firstFullCohort)</span></code></pre></div>
<table>
<thead>
<tr>
<th style="empty-cells: hide;border-bottom:hidden;" colspan="1">
</th>
<th style="border-bottom:hidden;padding-bottom:0; padding-left:3px;padding-right:3px;text-align: center; " colspan="2">
<div style="border-bottom: 1px solid #ddd; padding-bottom: 5px; ">
Participants
</div>
</th>
<th style="border-bottom:hidden;padding-bottom:0; padding-left:3px;padding-right:3px;text-align: center; " colspan="2">
<div style="border-bottom: 1px solid #ddd; padding-bottom: 5px; ">
Probability that dose is in
</div>
</th>
</tr>
<tr>
<th style="text-align:right;">
Dose
</th>
<th style="text-align:right;">
Treated
</th>
<th style="text-align:right;">
With DLT
</th>
<th style="text-align:right;">
Target range
</th>
<th style="text-align:right;">
Overdose range
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:right;">
1
</td>
<td style="text-align:right;">
1
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0.015
</td>
<td style="text-align:right;">
0.005
</td>
</tr>
<tr>
<td style="text-align:right;">
3
</td>
<td style="text-align:right;">
1
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0.012
</td>
<td style="text-align:right;">
0.012
</td>
</tr>
<tr>
<td style="text-align:right;">
9
</td>
<td style="text-align:right;">
1
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0.079
</td>
<td style="text-align:right;">
0.018
</td>
</tr>
<tr>
<td style="text-align:right;">
20
</td>
<td style="text-align:right;">
4
</td>
<td style="text-align:right;">
1
</td>
<td style="text-align:right;">
0.243
</td>
<td style="text-align:right;">
0.084
</td>
</tr>
<tr>
<td style="text-align:right;">
30
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0.322
</td>
<td style="text-align:right;">
0.226
</td>
</tr>
<tr>
<td style="text-align:right;">
45
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0.355
</td>
<td style="text-align:right;">
0.497
</td>
</tr>
<tr>
<td style="text-align:right;">
60
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0.244
</td>
<td style="text-align:right;">
0.719
</td>
</tr>
<tr>
<td style="text-align:right;">
80
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0.100
</td>
<td style="text-align:right;">
0.884
</td>
</tr>
<tr>
<td style="text-align:right;">
100
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0.047
</td>
<td style="text-align:right;">
0.943
</td>
</tr>
</tbody>
</table>
<p>Should the trial stop? If not, what dose should be used for the next
cohort?</p>
<div class="sourceCode" id="cb14"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb14-1"><a href="#cb14-1" tabindex="-1"></a>nextMaxDose <span class="ot">&lt;-</span> <span class="fu">maxDose</span>(my_increments, firstFullCohort)</span>
<span id="cb14-2"><a href="#cb14-2" tabindex="-1"></a>nextMaxDose</span>
<span id="cb14-3"><a href="#cb14-3" tabindex="-1"></a><span class="co">#&gt; [1] 40</span></span>
<span id="cb14-4"><a href="#cb14-4" tabindex="-1"></a></span>
<span id="cb14-5"><a href="#cb14-5" tabindex="-1"></a>doseRecommendation <span class="ot">&lt;-</span> <span class="fu">nextBest</span>(</span>
<span id="cb14-6"><a href="#cb14-6" tabindex="-1"></a>  my_next_best,</span>
<span id="cb14-7"><a href="#cb14-7" tabindex="-1"></a>  <span class="at">doselimit =</span> nextMaxDose,</span>
<span id="cb14-8"><a href="#cb14-8" tabindex="-1"></a>  <span class="at">samples =</span> postSamples1,</span>
<span id="cb14-9"><a href="#cb14-9" tabindex="-1"></a>  <span class="at">model =</span> model,</span>
<span id="cb14-10"><a href="#cb14-10" tabindex="-1"></a>  <span class="at">data =</span> firstFullCohort</span>
<span id="cb14-11"><a href="#cb14-11" tabindex="-1"></a>)</span>
<span id="cb14-12"><a href="#cb14-12" tabindex="-1"></a>doseRecommendation<span class="sc">$</span>value</span>
<span id="cb14-13"><a href="#cb14-13" tabindex="-1"></a><span class="co">#&gt; [1] 30</span></span>
<span id="cb14-14"><a href="#cb14-14" tabindex="-1"></a></span>
<span id="cb14-15"><a href="#cb14-15" tabindex="-1"></a>x <span class="ot">&lt;-</span> <span class="fu">stopTrial</span>(</span>
<span id="cb14-16"><a href="#cb14-16" tabindex="-1"></a>  my_stopping,</span>
<span id="cb14-17"><a href="#cb14-17" tabindex="-1"></a>  <span class="at">dose =</span> doseRecommendation<span class="sc">$</span>value,</span>
<span id="cb14-18"><a href="#cb14-18" tabindex="-1"></a>  postSamples1,</span>
<span id="cb14-19"><a href="#cb14-19" tabindex="-1"></a>  model,</span>
<span id="cb14-20"><a href="#cb14-20" tabindex="-1"></a>  firstFullCohort</span>
<span id="cb14-21"><a href="#cb14-21" tabindex="-1"></a>)</span>
<span id="cb14-22"><a href="#cb14-22" tabindex="-1"></a><span class="fu">attributes</span>(x) <span class="ot">&lt;-</span> <span class="cn">NULL</span></span>
<span id="cb14-23"><a href="#cb14-23" tabindex="-1"></a>x</span>
<span id="cb14-24"><a href="#cb14-24" tabindex="-1"></a><span class="co">#&gt; [1] FALSE</span></span></code></pre></div>
<p>So the trial should continue, treating three patients in the next
cohort at <code>30</code>.</p>
</div>
<div id="the-second-full-cohort" class="section level3">
<h3>The second full cohort</h3>
<p>Assume that none of the three patients in the next cohort report a
DLT:</p>
<div class="sourceCode" id="cb15"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb15-1"><a href="#cb15-1" tabindex="-1"></a>secondFullCohort <span class="ot">&lt;-</span> <span class="fu">Data</span>(</span>
<span id="cb15-2"><a href="#cb15-2" tabindex="-1"></a>  <span class="at">x =</span> <span class="fu">c</span>(<span class="dv">1</span>, <span class="dv">3</span>, <span class="dv">9</span>, <span class="dv">20</span>, <span class="dv">20</span>, <span class="dv">20</span>, <span class="dv">20</span>, <span class="dv">30</span>, <span class="dv">30</span>, <span class="dv">30</span>),</span>
<span id="cb15-3"><a href="#cb15-3" tabindex="-1"></a>  <span class="at">y =</span> <span class="fu">c</span>(<span class="dv">0</span>, <span class="dv">0</span>, <span class="dv">0</span>, <span class="dv">1</span>, <span class="dv">0</span>, <span class="dv">0</span>, <span class="dv">0</span>, <span class="dv">0</span>, <span class="dv">0</span>, <span class="dv">0</span>),</span>
<span id="cb15-4"><a href="#cb15-4" tabindex="-1"></a>  <span class="at">ID =</span> <span class="dv">1</span><span class="sc">:</span><span class="dv">10</span>,</span>
<span id="cb15-5"><a href="#cb15-5" tabindex="-1"></a>  <span class="at">cohort =</span> <span class="fu">c</span>(<span class="dv">1</span><span class="sc">:</span><span class="dv">4</span>, <span class="fu">rep</span>(<span class="dv">5</span>, <span class="dv">3</span>), <span class="fu">rep</span>(<span class="dv">6</span>, <span class="dv">3</span>)),</span>
<span id="cb15-6"><a href="#cb15-6" tabindex="-1"></a>  <span class="at">doseGrid =</span> doseGrid</span>
<span id="cb15-7"><a href="#cb15-7" tabindex="-1"></a>)</span></code></pre></div>
<p>Update the model:</p>
<div class="sourceCode" id="cb16"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb16-1"><a href="#cb16-1" tabindex="-1"></a>postSamples2 <span class="ot">&lt;-</span> <span class="fu">mcmc</span>(</span>
<span id="cb16-2"><a href="#cb16-2" tabindex="-1"></a>  <span class="at">data =</span> secondFullCohort,</span>
<span id="cb16-3"><a href="#cb16-3" tabindex="-1"></a>  <span class="at">model =</span> model,</span>
<span id="cb16-4"><a href="#cb16-4" tabindex="-1"></a>  <span class="at">options =</span> vignetteMcmcOptions</span>
<span id="cb16-5"><a href="#cb16-5" tabindex="-1"></a>)</span></code></pre></div>
<p>Tabulate the posterior:</p>
<div class="sourceCode" id="cb17"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb17-1"><a href="#cb17-1" tabindex="-1"></a><span class="fu">tabulatePosterior</span>(postSamples2, secondFullCohort)</span></code></pre></div>
<table>
<thead>
<tr>
<th style="empty-cells: hide;border-bottom:hidden;" colspan="1">
</th>
<th style="border-bottom:hidden;padding-bottom:0; padding-left:3px;padding-right:3px;text-align: center; " colspan="2">
<div style="border-bottom: 1px solid #ddd; padding-bottom: 5px; ">
Participants
</div>
</th>
<th style="border-bottom:hidden;padding-bottom:0; padding-left:3px;padding-right:3px;text-align: center; " colspan="2">
<div style="border-bottom: 1px solid #ddd; padding-bottom: 5px; ">
Probability that dose is in
</div>
</th>
</tr>
<tr>
<th style="text-align:right;">
Dose
</th>
<th style="text-align:right;">
Treated
</th>
<th style="text-align:right;">
With DLT
</th>
<th style="text-align:right;">
Target range
</th>
<th style="text-align:right;">
Overdose range
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:right;">
1
</td>
<td style="text-align:right;">
1
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0.001
</td>
<td style="text-align:right;">
0.000
</td>
</tr>
<tr>
<td style="text-align:right;">
3
</td>
<td style="text-align:right;">
1
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0.012
</td>
<td style="text-align:right;">
0.000
</td>
</tr>
<tr>
<td style="text-align:right;">
9
</td>
<td style="text-align:right;">
1
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0.029
</td>
<td style="text-align:right;">
0.004
</td>
</tr>
<tr>
<td style="text-align:right;">
20
</td>
<td style="text-align:right;">
4
</td>
<td style="text-align:right;">
1
</td>
<td style="text-align:right;">
0.141
</td>
<td style="text-align:right;">
0.026
</td>
</tr>
<tr>
<td style="text-align:right;">
30
</td>
<td style="text-align:right;">
3
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0.360
</td>
<td style="text-align:right;">
0.077
</td>
</tr>
<tr>
<td style="text-align:right;">
45
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0.406
</td>
<td style="text-align:right;">
0.330
</td>
</tr>
<tr>
<td style="text-align:right;">
60
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0.301
</td>
<td style="text-align:right;">
0.598
</td>
</tr>
<tr>
<td style="text-align:right;">
80
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0.143
</td>
<td style="text-align:right;">
0.823
</td>
</tr>
<tr>
<td style="text-align:right;">
100
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0.091
</td>
<td style="text-align:right;">
0.890
</td>
</tr>
</tbody>
</table>
<p>The dose with the highest posterior probability of being in the
target toxicity range is now <code>45</code>, but this dose also has an
unacceptably high probability of being in the overdose range. Therefore,
the trial should continue and the next cohort should be treated at
<code>30</code>:</p>
<div class="sourceCode" id="cb18"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb18-1"><a href="#cb18-1" tabindex="-1"></a>nextMaxDose <span class="ot">&lt;-</span> <span class="fu">maxDose</span>(my_increments, secondFullCohort)</span>
<span id="cb18-2"><a href="#cb18-2" tabindex="-1"></a>nextMaxDose</span>
<span id="cb18-3"><a href="#cb18-3" tabindex="-1"></a><span class="co">#&gt; [1] 45</span></span>
<span id="cb18-4"><a href="#cb18-4" tabindex="-1"></a></span>
<span id="cb18-5"><a href="#cb18-5" tabindex="-1"></a>doseRecommendation <span class="ot">&lt;-</span> <span class="fu">nextBest</span>(</span>
<span id="cb18-6"><a href="#cb18-6" tabindex="-1"></a>  my_next_best,</span>
<span id="cb18-7"><a href="#cb18-7" tabindex="-1"></a>  <span class="at">doselimit =</span> nextMaxDose,</span>
<span id="cb18-8"><a href="#cb18-8" tabindex="-1"></a>  <span class="at">samples =</span> postSamples2,</span>
<span id="cb18-9"><a href="#cb18-9" tabindex="-1"></a>  <span class="at">model =</span> model,</span>
<span id="cb18-10"><a href="#cb18-10" tabindex="-1"></a>  <span class="at">data =</span> secondFullCohort</span>
<span id="cb18-11"><a href="#cb18-11" tabindex="-1"></a>)</span>
<span id="cb18-12"><a href="#cb18-12" tabindex="-1"></a>doseRecommendation<span class="sc">$</span>value</span>
<span id="cb18-13"><a href="#cb18-13" tabindex="-1"></a><span class="co">#&gt; [1] 30</span></span>
<span id="cb18-14"><a href="#cb18-14" tabindex="-1"></a></span>
<span id="cb18-15"><a href="#cb18-15" tabindex="-1"></a>x <span class="ot">&lt;-</span> <span class="fu">stopTrial</span>(</span>
<span id="cb18-16"><a href="#cb18-16" tabindex="-1"></a>  my_stopping,</span>
<span id="cb18-17"><a href="#cb18-17" tabindex="-1"></a>  <span class="at">dose =</span> doseRecommendation<span class="sc">$</span>value,</span>
<span id="cb18-18"><a href="#cb18-18" tabindex="-1"></a>  postSamples2,</span>
<span id="cb18-19"><a href="#cb18-19" tabindex="-1"></a>  model,</span>
<span id="cb18-20"><a href="#cb18-20" tabindex="-1"></a>  secondFullCohort</span>
<span id="cb18-21"><a href="#cb18-21" tabindex="-1"></a>)</span>
<span id="cb18-22"><a href="#cb18-22" tabindex="-1"></a><span class="fu">attributes</span>(x) <span class="ot">&lt;-</span> <span class="cn">NULL</span></span>
<span id="cb18-23"><a href="#cb18-23" tabindex="-1"></a>x</span>
<span id="cb18-24"><a href="#cb18-24" tabindex="-1"></a><span class="co">#&gt; [1] FALSE</span></span></code></pre></div>
</div>
<div id="the-third-full-cohort" class="section level3">
<h3>The third full cohort</h3>
<p>Assume that none of the three patients in the third cohort report a
DLT:</p>
<div class="sourceCode" id="cb19"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb19-1"><a href="#cb19-1" tabindex="-1"></a>thirdFullCohort <span class="ot">&lt;-</span> <span class="fu">Data</span>(</span>
<span id="cb19-2"><a href="#cb19-2" tabindex="-1"></a>  <span class="at">x =</span> <span class="fu">c</span>(<span class="dv">1</span>, <span class="dv">3</span>, <span class="dv">9</span>, <span class="fu">rep</span>(<span class="dv">20</span>, <span class="dv">4</span>), <span class="fu">rep</span>(<span class="dv">30</span>, <span class="dv">6</span>)),</span>
<span id="cb19-3"><a href="#cb19-3" tabindex="-1"></a>  <span class="at">y =</span> <span class="fu">c</span>(<span class="dv">0</span>, <span class="dv">0</span>, <span class="dv">0</span>, <span class="dv">1</span>, <span class="fu">rep</span>(<span class="dv">0</span>, <span class="dv">9</span>)),</span>
<span id="cb19-4"><a href="#cb19-4" tabindex="-1"></a>  <span class="at">ID =</span> <span class="dv">1</span><span class="sc">:</span><span class="dv">13</span>,</span>
<span id="cb19-5"><a href="#cb19-5" tabindex="-1"></a>  <span class="at">cohort =</span> <span class="fu">c</span>(<span class="dv">1</span><span class="sc">:</span><span class="dv">4</span>, <span class="fu">rep</span>(<span class="dv">5</span>, <span class="dv">3</span>), <span class="fu">rep</span>(<span class="dv">6</span>, <span class="dv">3</span>), <span class="fu">rep</span>(<span class="dv">7</span>, <span class="dv">3</span>)),</span>
<span id="cb19-6"><a href="#cb19-6" tabindex="-1"></a>  <span class="at">doseGrid =</span> doseGrid</span>
<span id="cb19-7"><a href="#cb19-7" tabindex="-1"></a>)</span></code></pre></div>
<p>Update the model:</p>
<div class="sourceCode" id="cb20"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb20-1"><a href="#cb20-1" tabindex="-1"></a>postSamples3 <span class="ot">&lt;-</span> <span class="fu">mcmc</span>(</span>
<span id="cb20-2"><a href="#cb20-2" tabindex="-1"></a>  <span class="at">data =</span> thirdFullCohort,</span>
<span id="cb20-3"><a href="#cb20-3" tabindex="-1"></a>  <span class="at">model =</span> model,</span>
<span id="cb20-4"><a href="#cb20-4" tabindex="-1"></a>  <span class="at">options =</span> vignetteMcmcOptions</span>
<span id="cb20-5"><a href="#cb20-5" tabindex="-1"></a>)</span></code></pre></div>
<p>Tabulate the posterior:</p>
<div class="sourceCode" id="cb21"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb21-1"><a href="#cb21-1" tabindex="-1"></a><span class="fu">tabulatePosterior</span>(postSamples3, thirdFullCohort)</span></code></pre></div>
<table>
<thead>
<tr>
<th style="empty-cells: hide;border-bottom:hidden;" colspan="1">
</th>
<th style="border-bottom:hidden;padding-bottom:0; padding-left:3px;padding-right:3px;text-align: center; " colspan="2">
<div style="border-bottom: 1px solid #ddd; padding-bottom: 5px; ">
Participants
</div>
</th>
<th style="border-bottom:hidden;padding-bottom:0; padding-left:3px;padding-right:3px;text-align: center; " colspan="2">
<div style="border-bottom: 1px solid #ddd; padding-bottom: 5px; ">
Probability that dose is in
</div>
</th>
</tr>
<tr>
<th style="text-align:right;">
Dose
</th>
<th style="text-align:right;">
Treated
</th>
<th style="text-align:right;">
With DLT
</th>
<th style="text-align:right;">
Target range
</th>
<th style="text-align:right;">
Overdose range
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:right;">
1
</td>
<td style="text-align:right;">
1
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0.000
</td>
<td style="text-align:right;">
0.000
</td>
</tr>
<tr>
<td style="text-align:right;">
3
</td>
<td style="text-align:right;">
1
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0.003
</td>
<td style="text-align:right;">
0.000
</td>
</tr>
<tr>
<td style="text-align:right;">
9
</td>
<td style="text-align:right;">
1
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0.008
</td>
<td style="text-align:right;">
0.002
</td>
</tr>
<tr>
<td style="text-align:right;">
20
</td>
<td style="text-align:right;">
4
</td>
<td style="text-align:right;">
1
</td>
<td style="text-align:right;">
0.067
</td>
<td style="text-align:right;">
0.005
</td>
</tr>
<tr>
<td style="text-align:right;">
30
</td>
<td style="text-align:right;">
6
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0.193
</td>
<td style="text-align:right;">
0.032
</td>
</tr>
<tr>
<td style="text-align:right;">
45
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0.430
</td>
<td style="text-align:right;">
0.163
</td>
</tr>
<tr>
<td style="text-align:right;">
60
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0.337
</td>
<td style="text-align:right;">
0.493
</td>
</tr>
<tr>
<td style="text-align:right;">
80
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0.200
</td>
<td style="text-align:right;">
0.743
</td>
</tr>
<tr>
<td style="text-align:right;">
100
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0.124
</td>
<td style="text-align:right;">
0.847
</td>
</tr>
</tbody>
</table>
<p><code>45</code> is still the dose with the highest posterior
probability of being in the target toxicity range, and its probability
of being in the overdose range is now acceptable. Therefore, the trial
should continue and the next cohort should be treated at
<code>45</code>:</p>
<div class="sourceCode" id="cb22"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb22-1"><a href="#cb22-1" tabindex="-1"></a>nextMaxDose <span class="ot">&lt;-</span> <span class="fu">maxDose</span>(my_increments, thirdFullCohort)</span>
<span id="cb22-2"><a href="#cb22-2" tabindex="-1"></a>nextMaxDose</span>
<span id="cb22-3"><a href="#cb22-3" tabindex="-1"></a><span class="co">#&gt; [1] 45</span></span>
<span id="cb22-4"><a href="#cb22-4" tabindex="-1"></a></span>
<span id="cb22-5"><a href="#cb22-5" tabindex="-1"></a>doseRecommendation <span class="ot">&lt;-</span> <span class="fu">nextBest</span>(</span>
<span id="cb22-6"><a href="#cb22-6" tabindex="-1"></a>  my_next_best,</span>
<span id="cb22-7"><a href="#cb22-7" tabindex="-1"></a>  <span class="at">doselimit =</span> nextMaxDose,</span>
<span id="cb22-8"><a href="#cb22-8" tabindex="-1"></a>  <span class="at">samples =</span> postSamples3,</span>
<span id="cb22-9"><a href="#cb22-9" tabindex="-1"></a>  <span class="at">model =</span> model,</span>
<span id="cb22-10"><a href="#cb22-10" tabindex="-1"></a>  <span class="at">data =</span> thirdFullCohort</span>
<span id="cb22-11"><a href="#cb22-11" tabindex="-1"></a>)</span>
<span id="cb22-12"><a href="#cb22-12" tabindex="-1"></a>doseRecommendation<span class="sc">$</span>value</span>
<span id="cb22-13"><a href="#cb22-13" tabindex="-1"></a><span class="co">#&gt; [1] 45</span></span>
<span id="cb22-14"><a href="#cb22-14" tabindex="-1"></a></span>
<span id="cb22-15"><a href="#cb22-15" tabindex="-1"></a>x <span class="ot">&lt;-</span> <span class="fu">stopTrial</span>(</span>
<span id="cb22-16"><a href="#cb22-16" tabindex="-1"></a>  my_stopping,</span>
<span id="cb22-17"><a href="#cb22-17" tabindex="-1"></a>  <span class="at">dose =</span> doseRecommendation<span class="sc">$</span>value,</span>
<span id="cb22-18"><a href="#cb22-18" tabindex="-1"></a>  postSamples3,</span>
<span id="cb22-19"><a href="#cb22-19" tabindex="-1"></a>  model,</span>
<span id="cb22-20"><a href="#cb22-20" tabindex="-1"></a>  thirdFullCohort</span>
<span id="cb22-21"><a href="#cb22-21" tabindex="-1"></a>)</span>
<span id="cb22-22"><a href="#cb22-22" tabindex="-1"></a><span class="fu">attributes</span>(x) <span class="ot">&lt;-</span> <span class="cn">NULL</span></span>
<span id="cb22-23"><a href="#cb22-23" tabindex="-1"></a>x</span>
<span id="cb22-24"><a href="#cb22-24" tabindex="-1"></a><span class="co">#&gt; [1] FALSE</span></span></code></pre></div>
</div>
<div id="the-fourth-full-cohort" class="section level3">
<h3>The fourth full cohort</h3>
<p>Assume that none of the three patients in the fourth cohort report a
DLT:</p>
<div class="sourceCode" id="cb23"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb23-1"><a href="#cb23-1" tabindex="-1"></a>fourthFullCohort <span class="ot">&lt;-</span> <span class="fu">Data</span>(</span>
<span id="cb23-2"><a href="#cb23-2" tabindex="-1"></a>  <span class="at">x =</span> <span class="fu">c</span>(<span class="dv">1</span>, <span class="dv">3</span>, <span class="dv">9</span>, <span class="fu">rep</span>(<span class="dv">20</span>, <span class="dv">4</span>), <span class="fu">rep</span>(<span class="dv">30</span>, <span class="dv">6</span>), <span class="fu">rep</span>(<span class="dv">45</span>, <span class="dv">3</span>)),</span>
<span id="cb23-3"><a href="#cb23-3" tabindex="-1"></a>  <span class="at">y =</span> <span class="fu">c</span>(<span class="dv">0</span>, <span class="dv">0</span>, <span class="dv">0</span>, <span class="dv">1</span>, <span class="fu">rep</span>(<span class="dv">0</span>, <span class="dv">12</span>)),</span>
<span id="cb23-4"><a href="#cb23-4" tabindex="-1"></a>  <span class="at">ID =</span> <span class="dv">1</span><span class="sc">:</span><span class="dv">16</span>,</span>
<span id="cb23-5"><a href="#cb23-5" tabindex="-1"></a>  <span class="at">cohort =</span> <span class="fu">c</span>(<span class="dv">1</span><span class="sc">:</span><span class="dv">4</span>, <span class="fu">rep</span>(<span class="dv">5</span><span class="sc">:</span><span class="dv">8</span>, <span class="at">each =</span> <span class="dv">3</span>)),</span>
<span id="cb23-6"><a href="#cb23-6" tabindex="-1"></a>  <span class="at">doseGrid =</span> doseGrid</span>
<span id="cb23-7"><a href="#cb23-7" tabindex="-1"></a>)</span></code></pre></div>
<p>Update the model:</p>
<div class="sourceCode" id="cb24"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb24-1"><a href="#cb24-1" tabindex="-1"></a>postSamples4 <span class="ot">&lt;-</span> <span class="fu">mcmc</span>(</span>
<span id="cb24-2"><a href="#cb24-2" tabindex="-1"></a>  <span class="at">data =</span> fourthFullCohort,</span>
<span id="cb24-3"><a href="#cb24-3" tabindex="-1"></a>  <span class="at">model =</span> model,</span>
<span id="cb24-4"><a href="#cb24-4" tabindex="-1"></a>  <span class="at">options =</span> vignetteMcmcOptions</span>
<span id="cb24-5"><a href="#cb24-5" tabindex="-1"></a>)</span></code></pre></div>
<p>Tabulate the posterior:</p>
<div class="sourceCode" id="cb25"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb25-1"><a href="#cb25-1" tabindex="-1"></a><span class="fu">tabulatePosterior</span>(postSamples4, fourthFullCohort)</span></code></pre></div>
<table>
<thead>
<tr>
<th style="empty-cells: hide;border-bottom:hidden;" colspan="1">
</th>
<th style="border-bottom:hidden;padding-bottom:0; padding-left:3px;padding-right:3px;text-align: center; " colspan="2">
<div style="border-bottom: 1px solid #ddd; padding-bottom: 5px; ">
Participants
</div>
</th>
<th style="border-bottom:hidden;padding-bottom:0; padding-left:3px;padding-right:3px;text-align: center; " colspan="2">
<div style="border-bottom: 1px solid #ddd; padding-bottom: 5px; ">
Probability that dose is in
</div>
</th>
</tr>
<tr>
<th style="text-align:right;">
Dose
</th>
<th style="text-align:right;">
Treated
</th>
<th style="text-align:right;">
With DLT
</th>
<th style="text-align:right;">
Target range
</th>
<th style="text-align:right;">
Overdose range
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:right;">
1
</td>
<td style="text-align:right;">
1
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0.000
</td>
<td style="text-align:right;">
0.000
</td>
</tr>
<tr>
<td style="text-align:right;">
3
</td>
<td style="text-align:right;">
1
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0.002
</td>
<td style="text-align:right;">
0.000
</td>
</tr>
<tr>
<td style="text-align:right;">
9
</td>
<td style="text-align:right;">
1
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0.004
</td>
<td style="text-align:right;">
0.000
</td>
</tr>
<tr>
<td style="text-align:right;">
20
</td>
<td style="text-align:right;">
4
</td>
<td style="text-align:right;">
1
</td>
<td style="text-align:right;">
0.024
</td>
<td style="text-align:right;">
0.001
</td>
</tr>
<tr>
<td style="text-align:right;">
30
</td>
<td style="text-align:right;">
6
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0.112
</td>
<td style="text-align:right;">
0.006
</td>
</tr>
<tr>
<td style="text-align:right;">
45
</td>
<td style="text-align:right;">
3
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0.343
</td>
<td style="text-align:right;">
0.076
</td>
</tr>
<tr>
<td style="text-align:right;">
60
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0.425
</td>
<td style="text-align:right;">
0.322
</td>
</tr>
<tr>
<td style="text-align:right;">
80
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0.306
</td>
<td style="text-align:right;">
0.583
</td>
</tr>
<tr>
<td style="text-align:right;">
100
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0.179
</td>
<td style="text-align:right;">
0.757
</td>
</tr>
</tbody>
</table>
<p><code>60</code> is now the dose with the highest posterior
probability of being in the target toxicity range, but its probability
of being in the overdose range is unacceptable. Therefore, the trial
should continue and the next cohort should be treated at
<code>45</code>:</p>
<div class="sourceCode" id="cb26"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb26-1"><a href="#cb26-1" tabindex="-1"></a>nextMaxDose <span class="ot">&lt;-</span> <span class="fu">maxDose</span>(my_increments, fourthFullCohort)</span>
<span id="cb26-2"><a href="#cb26-2" tabindex="-1"></a>nextMaxDose</span>
<span id="cb26-3"><a href="#cb26-3" tabindex="-1"></a><span class="co">#&gt; [1] 67.5</span></span>
<span id="cb26-4"><a href="#cb26-4" tabindex="-1"></a></span>
<span id="cb26-5"><a href="#cb26-5" tabindex="-1"></a>doseRecommendation <span class="ot">&lt;-</span> <span class="fu">nextBest</span>(</span>
<span id="cb26-6"><a href="#cb26-6" tabindex="-1"></a>  my_next_best,</span>
<span id="cb26-7"><a href="#cb26-7" tabindex="-1"></a>  <span class="at">doselimit =</span> nextMaxDose,</span>
<span id="cb26-8"><a href="#cb26-8" tabindex="-1"></a>  <span class="at">samples =</span> postSamples4,</span>
<span id="cb26-9"><a href="#cb26-9" tabindex="-1"></a>  <span class="at">model =</span> model,</span>
<span id="cb26-10"><a href="#cb26-10" tabindex="-1"></a>  <span class="at">data =</span> fourthFullCohort</span>
<span id="cb26-11"><a href="#cb26-11" tabindex="-1"></a>)</span>
<span id="cb26-12"><a href="#cb26-12" tabindex="-1"></a>doseRecommendation<span class="sc">$</span>value</span>
<span id="cb26-13"><a href="#cb26-13" tabindex="-1"></a><span class="co">#&gt; [1] 45</span></span>
<span id="cb26-14"><a href="#cb26-14" tabindex="-1"></a></span>
<span id="cb26-15"><a href="#cb26-15" tabindex="-1"></a>x <span class="ot">&lt;-</span> <span class="fu">stopTrial</span>(</span>
<span id="cb26-16"><a href="#cb26-16" tabindex="-1"></a>  my_stopping,</span>
<span id="cb26-17"><a href="#cb26-17" tabindex="-1"></a>  <span class="at">dose =</span> doseRecommendation<span class="sc">$</span>value,</span>
<span id="cb26-18"><a href="#cb26-18" tabindex="-1"></a>  postSamples4,</span>
<span id="cb26-19"><a href="#cb26-19" tabindex="-1"></a>  model,</span>
<span id="cb26-20"><a href="#cb26-20" tabindex="-1"></a>  fourthFullCohort</span>
<span id="cb26-21"><a href="#cb26-21" tabindex="-1"></a>)</span>
<span id="cb26-22"><a href="#cb26-22" tabindex="-1"></a><span class="fu">attributes</span>(x) <span class="ot">&lt;-</span> <span class="cn">NULL</span></span>
<span id="cb26-23"><a href="#cb26-23" tabindex="-1"></a>x</span>
<span id="cb26-24"><a href="#cb26-24" tabindex="-1"></a><span class="co">#&gt; [1] FALSE</span></span></code></pre></div>
</div>
<div id="the-fifth-full-cohort" class="section level3">
<h3>The fifth full cohort</h3>
<p>Assume that two of the three patients in the fourth cohort report a
DLT:</p>
<div class="sourceCode" id="cb27"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb27-1"><a href="#cb27-1" tabindex="-1"></a>fifthFullCohort <span class="ot">&lt;-</span> <span class="fu">Data</span>(</span>
<span id="cb27-2"><a href="#cb27-2" tabindex="-1"></a>  <span class="at">x =</span> <span class="fu">c</span>(<span class="dv">1</span>, <span class="dv">3</span>, <span class="dv">9</span>, <span class="fu">rep</span>(<span class="dv">20</span>, <span class="dv">4</span>), <span class="fu">rep</span>(<span class="dv">30</span>, <span class="dv">6</span>), <span class="fu">rep</span>(<span class="dv">45</span>, <span class="dv">6</span>)),</span>
<span id="cb27-3"><a href="#cb27-3" tabindex="-1"></a>  <span class="at">y =</span> <span class="fu">c</span>(<span class="dv">0</span>, <span class="dv">0</span>, <span class="dv">0</span>, <span class="dv">1</span>, <span class="fu">rep</span>(<span class="dv">0</span>, <span class="dv">13</span>), <span class="dv">1</span>, <span class="dv">1</span>),</span>
<span id="cb27-4"><a href="#cb27-4" tabindex="-1"></a>  <span class="at">ID =</span> <span class="dv">1</span><span class="sc">:</span><span class="dv">19</span>,</span>
<span id="cb27-5"><a href="#cb27-5" tabindex="-1"></a>  <span class="at">cohort =</span> <span class="fu">c</span>(<span class="dv">1</span><span class="sc">:</span><span class="dv">4</span>, <span class="fu">rep</span>(<span class="dv">5</span><span class="sc">:</span><span class="dv">9</span>, <span class="at">each =</span> <span class="dv">3</span>)),</span>
<span id="cb27-6"><a href="#cb27-6" tabindex="-1"></a>  <span class="at">doseGrid =</span> doseGrid</span>
<span id="cb27-7"><a href="#cb27-7" tabindex="-1"></a>)</span></code></pre></div>
<p>Update the model:</p>
<div class="sourceCode" id="cb28"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb28-1"><a href="#cb28-1" tabindex="-1"></a>postSamples5 <span class="ot">&lt;-</span> <span class="fu">mcmc</span>(</span>
<span id="cb28-2"><a href="#cb28-2" tabindex="-1"></a>  <span class="at">data =</span> fifthFullCohort,</span>
<span id="cb28-3"><a href="#cb28-3" tabindex="-1"></a>  <span class="at">model =</span> model,</span>
<span id="cb28-4"><a href="#cb28-4" tabindex="-1"></a>  <span class="at">options =</span> vignetteMcmcOptions</span>
<span id="cb28-5"><a href="#cb28-5" tabindex="-1"></a>)</span></code></pre></div>
<p>Tabulate the posterior:</p>
<div class="sourceCode" id="cb29"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb29-1"><a href="#cb29-1" tabindex="-1"></a><span class="fu">tabulatePosterior</span>(postSamples5, fifthFullCohort)</span></code></pre></div>
<table>
<thead>
<tr>
<th style="empty-cells: hide;border-bottom:hidden;" colspan="1">
</th>
<th style="border-bottom:hidden;padding-bottom:0; padding-left:3px;padding-right:3px;text-align: center; " colspan="2">
<div style="border-bottom: 1px solid #ddd; padding-bottom: 5px; ">
Participants
</div>
</th>
<th style="border-bottom:hidden;padding-bottom:0; padding-left:3px;padding-right:3px;text-align: center; " colspan="2">
<div style="border-bottom: 1px solid #ddd; padding-bottom: 5px; ">
Probability that dose is in
</div>
</th>
</tr>
<tr>
<th style="text-align:right;">
Dose
</th>
<th style="text-align:right;">
Treated
</th>
<th style="text-align:right;">
With DLT
</th>
<th style="text-align:right;">
Target range
</th>
<th style="text-align:right;">
Overdose range
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:right;">
1
</td>
<td style="text-align:right;">
1
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0.000
</td>
<td style="text-align:right;">
0.000
</td>
</tr>
<tr>
<td style="text-align:right;">
3
</td>
<td style="text-align:right;">
1
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0.006
</td>
<td style="text-align:right;">
0.000
</td>
</tr>
<tr>
<td style="text-align:right;">
9
</td>
<td style="text-align:right;">
1
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0.010
</td>
<td style="text-align:right;">
0.002
</td>
</tr>
<tr>
<td style="text-align:right;">
20
</td>
<td style="text-align:right;">
4
</td>
<td style="text-align:right;">
1
</td>
<td style="text-align:right;">
0.068
</td>
<td style="text-align:right;">
0.005
</td>
</tr>
<tr>
<td style="text-align:right;">
30
</td>
<td style="text-align:right;">
6
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0.236
</td>
<td style="text-align:right;">
0.024
</td>
</tr>
<tr>
<td style="text-align:right;">
45
</td>
<td style="text-align:right;">
6
</td>
<td style="text-align:right;">
2
</td>
<td style="text-align:right;">
0.539
</td>
<td style="text-align:right;">
0.187
</td>
</tr>
<tr>
<td style="text-align:right;">
60
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0.355
</td>
<td style="text-align:right;">
0.572
</td>
</tr>
<tr>
<td style="text-align:right;">
80
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0.146
</td>
<td style="text-align:right;">
0.834
</td>
</tr>
<tr>
<td style="text-align:right;">
100
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0
</td>
<td style="text-align:right;">
0.081
</td>
<td style="text-align:right;">
0.914
</td>
</tr>
</tbody>
</table>
<p><code>45</code> remains the dose with the highest posterior
probability of being in the target toxicity range, and its probability
of being in the overdose range is acceptable. Moreover, the probability
that <code>45</code> is in the target toxicity range is above 0.5 and
more than three cohorts have been treated in total. Therefore, the trial
should stop and conclude that <code>45</code> is the MTD:</p>
<div class="sourceCode" id="cb30"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb30-1"><a href="#cb30-1" tabindex="-1"></a>nextMaxDose <span class="ot">&lt;-</span> <span class="fu">maxDose</span>(my_increments, fifthFullCohort)</span>
<span id="cb30-2"><a href="#cb30-2" tabindex="-1"></a>nextMaxDose</span>
<span id="cb30-3"><a href="#cb30-3" tabindex="-1"></a><span class="co">#&gt; [1] 67.5</span></span>
<span id="cb30-4"><a href="#cb30-4" tabindex="-1"></a></span>
<span id="cb30-5"><a href="#cb30-5" tabindex="-1"></a>doseRecommendation <span class="ot">&lt;-</span> <span class="fu">nextBest</span>(</span>
<span id="cb30-6"><a href="#cb30-6" tabindex="-1"></a>  my_next_best,</span>
<span id="cb30-7"><a href="#cb30-7" tabindex="-1"></a>  <span class="at">doselimit =</span> nextMaxDose,</span>
<span id="cb30-8"><a href="#cb30-8" tabindex="-1"></a>  <span class="at">samples =</span> postSamples5,</span>
<span id="cb30-9"><a href="#cb30-9" tabindex="-1"></a>  <span class="at">model =</span> model,</span>
<span id="cb30-10"><a href="#cb30-10" tabindex="-1"></a>  <span class="at">data =</span> fifthFullCohort</span>
<span id="cb30-11"><a href="#cb30-11" tabindex="-1"></a>)</span>
<span id="cb30-12"><a href="#cb30-12" tabindex="-1"></a>doseRecommendation<span class="sc">$</span>value</span>
<span id="cb30-13"><a href="#cb30-13" tabindex="-1"></a><span class="co">#&gt; [1] 45</span></span>
<span id="cb30-14"><a href="#cb30-14" tabindex="-1"></a></span>
<span id="cb30-15"><a href="#cb30-15" tabindex="-1"></a>x <span class="ot">&lt;-</span> <span class="fu">stopTrial</span>(</span>
<span id="cb30-16"><a href="#cb30-16" tabindex="-1"></a>  my_stopping,</span>
<span id="cb30-17"><a href="#cb30-17" tabindex="-1"></a>  <span class="at">dose =</span> doseRecommendation<span class="sc">$</span>value,</span>
<span id="cb30-18"><a href="#cb30-18" tabindex="-1"></a>  postSamples5,</span>
<span id="cb30-19"><a href="#cb30-19" tabindex="-1"></a>  model,</span>
<span id="cb30-20"><a href="#cb30-20" tabindex="-1"></a>  fifthFullCohort</span>
<span id="cb30-21"><a href="#cb30-21" tabindex="-1"></a>)</span>
<span id="cb30-22"><a href="#cb30-22" tabindex="-1"></a>x</span>
<span id="cb30-23"><a href="#cb30-23" tabindex="-1"></a><span class="co">#&gt; [1] TRUE</span></span>
<span id="cb30-24"><a href="#cb30-24" tabindex="-1"></a><span class="co">#&gt; attr(,&quot;message&quot;)</span></span>
<span id="cb30-25"><a href="#cb30-25" tabindex="-1"></a><span class="co">#&gt; attr(,&quot;message&quot;)[[1]]</span></span>
<span id="cb30-26"><a href="#cb30-26" tabindex="-1"></a><span class="co">#&gt; attr(,&quot;message&quot;)[[1]][[1]]</span></span>
<span id="cb30-27"><a href="#cb30-27" tabindex="-1"></a><span class="co">#&gt; [1] &quot;Number of cohorts is 9 and thus reached the prespecified minimum number 3&quot;</span></span>
<span id="cb30-28"><a href="#cb30-28" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb30-29"><a href="#cb30-29" tabindex="-1"></a><span class="co">#&gt; attr(,&quot;message&quot;)[[1]][[2]]</span></span>
<span id="cb30-30"><a href="#cb30-30" tabindex="-1"></a><span class="co">#&gt; [1] &quot;Probability for target toxicity is 54 % for dose 45 and thus above the required 50 %&quot;</span></span>
<span id="cb30-31"><a href="#cb30-31" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb30-32"><a href="#cb30-32" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb30-33"><a href="#cb30-33" tabindex="-1"></a><span class="co">#&gt; attr(,&quot;message&quot;)[[2]]</span></span>
<span id="cb30-34"><a href="#cb30-34" tabindex="-1"></a><span class="co">#&gt; [1] &quot;Number of patients is 19 and thus below the prespecified minimum number 20&quot;</span></span>
<span id="cb30-35"><a href="#cb30-35" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb30-36"><a href="#cb30-36" tabindex="-1"></a><span class="co">#&gt; attr(,&quot;individual&quot;)</span></span>
<span id="cb30-37"><a href="#cb30-37" tabindex="-1"></a><span class="co">#&gt; attr(,&quot;individual&quot;)[[1]]</span></span>
<span id="cb30-38"><a href="#cb30-38" tabindex="-1"></a><span class="co">#&gt; [1] TRUE</span></span>
<span id="cb30-39"><a href="#cb30-39" tabindex="-1"></a><span class="co">#&gt; attr(,&quot;message&quot;)</span></span>
<span id="cb30-40"><a href="#cb30-40" tabindex="-1"></a><span class="co">#&gt; attr(,&quot;message&quot;)[[1]]</span></span>
<span id="cb30-41"><a href="#cb30-41" tabindex="-1"></a><span class="co">#&gt; [1] &quot;Number of cohorts is 9 and thus reached the prespecified minimum number 3&quot;</span></span>
<span id="cb30-42"><a href="#cb30-42" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb30-43"><a href="#cb30-43" tabindex="-1"></a><span class="co">#&gt; attr(,&quot;message&quot;)[[2]]</span></span>
<span id="cb30-44"><a href="#cb30-44" tabindex="-1"></a><span class="co">#&gt; [1] &quot;Probability for target toxicity is 54 % for dose 45 and thus above the required 50 %&quot;</span></span>
<span id="cb30-45"><a href="#cb30-45" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb30-46"><a href="#cb30-46" tabindex="-1"></a><span class="co">#&gt; attr(,&quot;individual&quot;)</span></span>
<span id="cb30-47"><a href="#cb30-47" tabindex="-1"></a><span class="co">#&gt; attr(,&quot;individual&quot;)[[1]]</span></span>
<span id="cb30-48"><a href="#cb30-48" tabindex="-1"></a><span class="co">#&gt; [1] TRUE</span></span>
<span id="cb30-49"><a href="#cb30-49" tabindex="-1"></a><span class="co">#&gt; attr(,&quot;message&quot;)</span></span>
<span id="cb30-50"><a href="#cb30-50" tabindex="-1"></a><span class="co">#&gt; [1] &quot;Number of cohorts is 9 and thus reached the prespecified minimum number 3&quot;</span></span>
<span id="cb30-51"><a href="#cb30-51" tabindex="-1"></a><span class="co">#&gt; attr(,&quot;report_label&quot;)</span></span>
<span id="cb30-52"><a href="#cb30-52" tabindex="-1"></a><span class="co">#&gt; [1] &quot;≥ 3 cohorts dosed&quot;</span></span>
<span id="cb30-53"><a href="#cb30-53" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb30-54"><a href="#cb30-54" tabindex="-1"></a><span class="co">#&gt; attr(,&quot;individual&quot;)[[2]]</span></span>
<span id="cb30-55"><a href="#cb30-55" tabindex="-1"></a><span class="co">#&gt; [1] TRUE</span></span>
<span id="cb30-56"><a href="#cb30-56" tabindex="-1"></a><span class="co">#&gt; attr(,&quot;message&quot;)</span></span>
<span id="cb30-57"><a href="#cb30-57" tabindex="-1"></a><span class="co">#&gt; [1] &quot;Probability for target toxicity is 54 % for dose 45 and thus above the required 50 %&quot;</span></span>
<span id="cb30-58"><a href="#cb30-58" tabindex="-1"></a><span class="co">#&gt; attr(,&quot;report_label&quot;)</span></span>
<span id="cb30-59"><a href="#cb30-59" tabindex="-1"></a><span class="co">#&gt; [1] &quot;P(0.2 ≤ prob(DLE | NBD) ≤ 0.35) ≥ 0.5&quot;</span></span>
<span id="cb30-60"><a href="#cb30-60" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb30-61"><a href="#cb30-61" tabindex="-1"></a><span class="co">#&gt; attr(,&quot;report_label&quot;)</span></span>
<span id="cb30-62"><a href="#cb30-62" tabindex="-1"></a><span class="co">#&gt; [1] NA</span></span>
<span id="cb30-63"><a href="#cb30-63" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb30-64"><a href="#cb30-64" tabindex="-1"></a><span class="co">#&gt; attr(,&quot;individual&quot;)[[2]]</span></span>
<span id="cb30-65"><a href="#cb30-65" tabindex="-1"></a><span class="co">#&gt; [1] FALSE</span></span>
<span id="cb30-66"><a href="#cb30-66" tabindex="-1"></a><span class="co">#&gt; attr(,&quot;message&quot;)</span></span>
<span id="cb30-67"><a href="#cb30-67" tabindex="-1"></a><span class="co">#&gt; [1] &quot;Number of patients is 19 and thus below the prespecified minimum number 20&quot;</span></span>
<span id="cb30-68"><a href="#cb30-68" tabindex="-1"></a><span class="co">#&gt; attr(,&quot;report_label&quot;)</span></span>
<span id="cb30-69"><a href="#cb30-69" tabindex="-1"></a><span class="co">#&gt; [1] &quot;≥ 20 patients dosed&quot;</span></span>
<span id="cb30-70"><a href="#cb30-70" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb30-71"><a href="#cb30-71" tabindex="-1"></a><span class="co">#&gt; attr(,&quot;report_label&quot;)</span></span>
<span id="cb30-72"><a href="#cb30-72" tabindex="-1"></a><span class="co">#&gt; [1] NA</span></span></code></pre></div>
</div>
</div>
<div id="summarising-the-trial-results" class="section level2">
<h2>Summarising the trial results</h2>
<p>crmPack provides a wealth of information about the trial’s results.
The following code snippets illustrate some of the many possibilities
for how the trial might be summarised.</p>
<div class="sourceCode" id="cb31"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb31-1"><a href="#cb31-1" tabindex="-1"></a><span class="fu">plot</span>(fifthFullCohort)</span></code></pre></div>
<p><img role="img" aria-label="A visual representation of the data after nineteen participants have been treated.  One each at doses 1, 3 and 9; four at a dose of 20; 6 at a dose of 30 and 6 at a dose of 45.  Toxicitiues were reported by participants 4 (at a dose of 20) and 18 and 19 (both at a dose of 45)." src="data:image/png;base64,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" alt="A visual representation of the data after nineteen participants have been treated.  One each at doses 1, 3 and 9; four at a dose of 20; 6 at a dose of 30 and 6 at a dose of 45.  Toxicitiues were reported by participants 4 (at a dose of 20) and 18 and 19 (both at a dose of 45)." /></p>
<p><code>{rfig.alt = &quot;A plot of the posterior after nineteen participants have been treated.  The mean probability of toxicity increases smoothly from about zero percent at a dose of zero to about 55% at a dose of 100.  The confidence interval extends from 0% to about 6% at a dose of zero and from about 22% to  about 90% at a dose of 100.&quot;} plot(postSamples5, model, fifthFullCohort)</code></p>
<p><code>{rfig.alt = &quot;Two graphs arranged in a single column.  The upper graph shoes green lines of various heights that show the probability each dose is in the target toxicity range.  There is a big arrow pointing to the bar at a dose of 45, indicating that this dose has the highest probability of being in the target toxicity range.  The lower graph as a similar series of red lines, indicating the probability that each dose is in the overdose range.  There is a horizontal black dashed line at 25%, indicating that this is the highest acceptable probability of being in the overdose range.  The red bars for doses of 60 and above all extend above 25%, indicating that their toxicity is unacceptable.  The toxicity for doses of 45 and below lie below 25%.&quot;} doseRecommendation$plot</code></p>
<p>With a little bit of work, we can obtain a more detailed summary and
plot of the posterior probabilities of toxicity at each dose:</p>
<div class="sourceCode" id="cb32"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb32-1"><a href="#cb32-1" tabindex="-1"></a><span class="fu">slotNames</span>(model)</span>
<span id="cb32-2"><a href="#cb32-2" tabindex="-1"></a><span class="co">#&gt; [1] &quot;params&quot;          &quot;ref_dose&quot;        &quot;datamodel&quot;       &quot;priormodel&quot;     </span></span>
<span id="cb32-3"><a href="#cb32-3" tabindex="-1"></a><span class="co">#&gt; [5] &quot;modelspecs&quot;      &quot;init&quot;            &quot;datanames&quot;       &quot;datanames_prior&quot;</span></span>
<span id="cb32-4"><a href="#cb32-4" tabindex="-1"></a><span class="co">#&gt; [9] &quot;sample&quot;</span></span>
<span id="cb32-5"><a href="#cb32-5" tabindex="-1"></a></span>
<span id="cb32-6"><a href="#cb32-6" tabindex="-1"></a>fullSamples <span class="ot">&lt;-</span> <span class="fu">tibble</span>(</span>
<span id="cb32-7"><a href="#cb32-7" tabindex="-1"></a>  <span class="at">Alpha =</span> postSamples5<span class="sc">@</span>data<span class="sc">$</span>alpha0,</span>
<span id="cb32-8"><a href="#cb32-8" tabindex="-1"></a>  <span class="at">Beta =</span> postSamples5<span class="sc">@</span>data<span class="sc">$</span>alpha1</span>
<span id="cb32-9"><a href="#cb32-9" tabindex="-1"></a>) <span class="sc">%&gt;%</span></span>
<span id="cb32-10"><a href="#cb32-10" tabindex="-1"></a>  <span class="fu">expand</span>(<span class="fu">nesting</span>(Alpha, Beta), <span class="at">Dose =</span> doseGrid) <span class="sc">%&gt;%</span></span>
<span id="cb32-11"><a href="#cb32-11" tabindex="-1"></a>  <span class="fu">rowwise</span>() <span class="sc">%&gt;%</span></span>
<span id="cb32-12"><a href="#cb32-12" tabindex="-1"></a>  <span class="fu">mutate</span>(<span class="at">P =</span> <span class="fu">probFunction</span>(model, <span class="at">alpha0 =</span> Alpha, <span class="at">alpha1 =</span> Beta)(<span class="at">dose =</span> Dose)) <span class="sc">%&gt;%</span></span>
<span id="cb32-13"><a href="#cb32-13" tabindex="-1"></a>  <span class="fu">ungroup</span>()</span>
<span id="cb32-14"><a href="#cb32-14" tabindex="-1"></a></span>
<span id="cb32-15"><a href="#cb32-15" tabindex="-1"></a>fullSummary <span class="ot">&lt;-</span> fullSamples <span class="sc">%&gt;%</span></span>
<span id="cb32-16"><a href="#cb32-16" tabindex="-1"></a>  <span class="fu">group_by</span>(Dose) <span class="sc">%&gt;%</span></span>
<span id="cb32-17"><a href="#cb32-17" tabindex="-1"></a>  <span class="fu">summarise</span>(</span>
<span id="cb32-18"><a href="#cb32-18" tabindex="-1"></a>    <span class="at">Mean =</span> <span class="fu">mean</span>(P),</span>
<span id="cb32-19"><a href="#cb32-19" tabindex="-1"></a>    <span class="at">Median =</span> <span class="fu">median</span>(P),</span>
<span id="cb32-20"><a href="#cb32-20" tabindex="-1"></a>    <span class="at">Q =</span> <span class="fu">list</span>(<span class="fu">quantile</span>(P, <span class="at">probs =</span> <span class="fu">c</span>(<span class="fl">0.05</span>, <span class="fl">0.1</span>, <span class="fl">0.25</span>, <span class="fl">0.75</span>, <span class="fl">0.9</span>, <span class="fl">0.95</span>), <span class="at">na.rm =</span> <span class="cn">TRUE</span>))</span>
<span id="cb32-21"><a href="#cb32-21" tabindex="-1"></a>  ) <span class="sc">%&gt;%</span></span>
<span id="cb32-22"><a href="#cb32-22" tabindex="-1"></a>  <span class="fu">unnest_wider</span>(</span>
<span id="cb32-23"><a href="#cb32-23" tabindex="-1"></a>    <span class="at">col =</span> Q,</span>
<span id="cb32-24"><a href="#cb32-24" tabindex="-1"></a>    <span class="at">names_repair =</span> <span class="cf">function</span>(.x) {</span>
<span id="cb32-25"><a href="#cb32-25" tabindex="-1"></a>      <span class="fu">ifelse</span>(</span>
<span id="cb32-26"><a href="#cb32-26" tabindex="-1"></a>        <span class="fu">str_detect</span>(.x, <span class="st">&quot;</span><span class="sc">\\</span><span class="st">d+%&quot;</span>),</span>
<span id="cb32-27"><a href="#cb32-27" tabindex="-1"></a>        <span class="fu">sprintf</span>(<span class="st">&quot;Q%02.0f&quot;</span>, <span class="fu">as.numeric</span>(<span class="fu">str_remove_all</span>(.x, <span class="st">&quot;%&quot;</span>))),</span>
<span id="cb32-28"><a href="#cb32-28" tabindex="-1"></a>        .x</span>
<span id="cb32-29"><a href="#cb32-29" tabindex="-1"></a>      )</span>
<span id="cb32-30"><a href="#cb32-30" tabindex="-1"></a>    }</span>
<span id="cb32-31"><a href="#cb32-31" tabindex="-1"></a>  )</span>
<span id="cb32-32"><a href="#cb32-32" tabindex="-1"></a><span class="co">#&gt; Warning in sprintf(&quot;Q%02.0f&quot;, as.numeric(str_remove_all(.x, &quot;%&quot;))): NAs</span></span>
<span id="cb32-33"><a href="#cb32-33" tabindex="-1"></a><span class="co">#&gt; introduced by coercion</span></span>
<span id="cb32-34"><a href="#cb32-34" tabindex="-1"></a></span>
<span id="cb32-35"><a href="#cb32-35" tabindex="-1"></a>fullSummary <span class="sc">%&gt;%</span></span>
<span id="cb32-36"><a href="#cb32-36" tabindex="-1"></a>  kableExtra<span class="sc">::</span><span class="fu">kable</span>(</span>
<span id="cb32-37"><a href="#cb32-37" tabindex="-1"></a>    <span class="at">col.names =</span> <span class="fu">c</span>(<span class="st">&quot;Dose&quot;</span>, <span class="st">&quot;Mean&quot;</span>, <span class="st">&quot;Median&quot;</span>, <span class="st">&quot;5th&quot;</span>, <span class="st">&quot;10th&quot;</span>, <span class="st">&quot;25th&quot;</span>, <span class="st">&quot;75th&quot;</span>, <span class="st">&quot;90th&quot;</span>, <span class="st">&quot;95th&quot;</span>),</span>
<span id="cb32-38"><a href="#cb32-38" tabindex="-1"></a>    <span class="at">digits =</span> <span class="fu">c</span>(<span class="dv">0</span>, <span class="fu">rep</span>(<span class="dv">3</span>, <span class="dv">8</span>))</span>
<span id="cb32-39"><a href="#cb32-39" tabindex="-1"></a>  ) <span class="sc">%&gt;%</span></span>
<span id="cb32-40"><a href="#cb32-40" tabindex="-1"></a>  <span class="fu">add_header_above</span>(<span class="fu">c</span>(<span class="st">&quot; &quot;</span> <span class="ot">=</span> <span class="dv">3</span>, <span class="st">&quot;Quantiles&quot;</span> <span class="ot">=</span> <span class="dv">6</span>)) <span class="sc">%&gt;%</span></span>
<span id="cb32-41"><a href="#cb32-41" tabindex="-1"></a>  <span class="fu">add_header_above</span>(<span class="fu">c</span>(<span class="st">&quot; &quot;</span> <span class="ot">=</span> <span class="dv">1</span>, <span class="st">&quot;P(Toxicity)&quot;</span> <span class="ot">=</span> <span class="dv">8</span>))</span></code></pre></div>
<table>
<thead>
<tr>
<th style="empty-cells: hide;border-bottom:hidden;" colspan="1">
</th>
<th style="border-bottom:hidden;padding-bottom:0; padding-left:3px;padding-right:3px;text-align: center; " colspan="8">
<div style="border-bottom: 1px solid #ddd; padding-bottom: 5px; ">
P(Toxicity)
</div>
</th>
</tr>
<tr>
<th style="empty-cells: hide;border-bottom:hidden;" colspan="3">
</th>
<th style="border-bottom:hidden;padding-bottom:0; padding-left:3px;padding-right:3px;text-align: center; " colspan="6">
<div style="border-bottom: 1px solid #ddd; padding-bottom: 5px; ">
Quantiles
</div>
</th>
</tr>
<tr>
<th style="text-align:right;">
Dose
</th>
<th style="text-align:right;">
Mean
</th>
<th style="text-align:right;">
Median
</th>
<th style="text-align:right;">
5th
</th>
<th style="text-align:right;">
10th
</th>
<th style="text-align:right;">
25th
</th>
<th style="text-align:right;">
75th
</th>
<th style="text-align:right;">
90th
</th>
<th style="text-align:right;">
95th
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:right;">
1
</td>
<td style="text-align:right;">
0.006
</td>
<td style="text-align:right;">
0.000
</td>
<td style="text-align:right;">
0.000
</td>
<td style="text-align:right;">
0.000
</td>
<td style="text-align:right;">
0.000
</td>
<td style="text-align:right;">
0.003
</td>
<td style="text-align:right;">
0.015
</td>
<td style="text-align:right;">
0.027
</td>
</tr>
<tr>
<td style="text-align:right;">
3
</td>
<td style="text-align:right;">
0.013
</td>
<td style="text-align:right;">
0.003
</td>
<td style="text-align:right;">
0.000
</td>
<td style="text-align:right;">
0.000
</td>
<td style="text-align:right;">
0.000
</td>
<td style="text-align:right;">
0.014
</td>
<td style="text-align:right;">
0.036
</td>
<td style="text-align:right;">
0.058
</td>
</tr>
<tr>
<td style="text-align:right;">
9
</td>
<td style="text-align:right;">
0.036
</td>
<td style="text-align:right;">
0.018
</td>
<td style="text-align:right;">
0.001
</td>
<td style="text-align:right;">
0.001
</td>
<td style="text-align:right;">
0.005
</td>
<td style="text-align:right;">
0.049
</td>
<td style="text-align:right;">
0.097
</td>
<td style="text-align:right;">
0.124
</td>
</tr>
<tr>
<td style="text-align:right;">
20
</td>
<td style="text-align:right;">
0.090
</td>
<td style="text-align:right;">
0.073
</td>
<td style="text-align:right;">
0.010
</td>
<td style="text-align:right;">
0.015
</td>
<td style="text-align:right;">
0.034
</td>
<td style="text-align:right;">
0.126
</td>
<td style="text-align:right;">
0.193
</td>
<td style="text-align:right;">
0.230
</td>
</tr>
<tr>
<td style="text-align:right;">
30
</td>
<td style="text-align:right;">
0.153
</td>
<td style="text-align:right;">
0.137
</td>
<td style="text-align:right;">
0.040
</td>
<td style="text-align:right;">
0.051
</td>
<td style="text-align:right;">
0.084
</td>
<td style="text-align:right;">
0.209
</td>
<td style="text-align:right;">
0.275
</td>
<td style="text-align:right;">
0.314
</td>
</tr>
<tr>
<td style="text-align:right;">
45
</td>
<td style="text-align:right;">
0.266
</td>
<td style="text-align:right;">
0.260
</td>
<td style="text-align:right;">
0.100
</td>
<td style="text-align:right;">
0.135
</td>
<td style="text-align:right;">
0.186
</td>
<td style="text-align:right;">
0.335
</td>
<td style="text-align:right;">
0.411
</td>
<td style="text-align:right;">
0.469
</td>
</tr>
<tr>
<td style="text-align:right;">
60
</td>
<td style="text-align:right;">
0.381
</td>
<td style="text-align:right;">
0.363
</td>
<td style="text-align:right;">
0.174
</td>
<td style="text-align:right;">
0.211
</td>
<td style="text-align:right;">
0.277
</td>
<td style="text-align:right;">
0.490
</td>
<td style="text-align:right;">
0.579
</td>
<td style="text-align:right;">
0.619
</td>
</tr>
<tr>
<td style="text-align:right;">
80
</td>
<td style="text-align:right;">
0.506
</td>
<td style="text-align:right;">
0.484
</td>
<td style="text-align:right;">
0.241
</td>
<td style="text-align:right;">
0.297
</td>
<td style="text-align:right;">
0.375
</td>
<td style="text-align:right;">
0.645
</td>
<td style="text-align:right;">
0.743
</td>
<td style="text-align:right;">
0.806
</td>
</tr>
<tr>
<td style="text-align:right;">
100
</td>
<td style="text-align:right;">
0.594
</td>
<td style="text-align:right;">
0.585
</td>
<td style="text-align:right;">
0.291
</td>
<td style="text-align:right;">
0.347
</td>
<td style="text-align:right;">
0.448
</td>
<td style="text-align:right;">
0.750
</td>
<td style="text-align:right;">
0.849
</td>
<td style="text-align:right;">
0.902
</td>
</tr>
</tbody>
</table>
<div class="sourceCode" id="cb33"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb33-1"><a href="#cb33-1" tabindex="-1"></a></span>
<span id="cb33-2"><a href="#cb33-2" tabindex="-1"></a>fullSamples <span class="sc">%&gt;%</span></span>
<span id="cb33-3"><a href="#cb33-3" tabindex="-1"></a>  <span class="fu">filter</span>(Dose <span class="sc">&gt;</span> <span class="dv">9</span>) <span class="sc">%&gt;%</span></span>
<span id="cb33-4"><a href="#cb33-4" tabindex="-1"></a>  <span class="fu">ggplot</span>() <span class="sc">+</span></span>
<span id="cb33-5"><a href="#cb33-5" tabindex="-1"></a>  <span class="fu">geom_density</span>(<span class="fu">aes</span>(<span class="at">x =</span> P, <span class="at">color =</span> <span class="fu">as.factor</span>(Dose))) <span class="sc">+</span></span>
<span id="cb33-6"><a href="#cb33-6" tabindex="-1"></a>  <span class="fu">theme_light</span>() <span class="sc">+</span></span>
<span id="cb33-7"><a href="#cb33-7" tabindex="-1"></a>  <span class="fu">theme</span>(</span>
<span id="cb33-8"><a href="#cb33-8" tabindex="-1"></a>    <span class="at">axis.text.y =</span> <span class="fu">element_blank</span>(),</span>
<span id="cb33-9"><a href="#cb33-9" tabindex="-1"></a>    <span class="at">axis.title.y =</span> <span class="fu">element_blank</span>(),</span>
<span id="cb33-10"><a href="#cb33-10" tabindex="-1"></a>    <span class="at">axis.ticks.y =</span> <span class="fu">element_blank</span>()</span>
<span id="cb33-11"><a href="#cb33-11" tabindex="-1"></a>  ) <span class="sc">+</span></span>
<span id="cb33-12"><a href="#cb33-12" tabindex="-1"></a>  <span class="fu">labs</span>(</span>
<span id="cb33-13"><a href="#cb33-13" tabindex="-1"></a>    <span class="at">title =</span> <span class="st">&quot;Posterior PDFs for doses &gt; 9&quot;</span>,</span>
<span id="cb33-14"><a href="#cb33-14" tabindex="-1"></a>    <span class="at">colour =</span> <span class="st">&quot;Dose&quot;</span></span>
<span id="cb33-15"><a href="#cb33-15" tabindex="-1"></a>  )</span></code></pre></div>
<p><img role="img" aria-label="A graph showing the posterior density of of the probability of toxicity for all doses greater than nine.  The mode of each density moves to the right as dose increases.  The densities for low doses are heaviliy skewed to the left.  Densities for higher doses are more symmetric and flatter." src="data:image/png;base64,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" alt="A graph showing the posterior density of of the probability of toxicity for all doses greater than nine.  The mode of each density moves to the right as dose increases.  The densities for low doses are heaviliy skewed to the left.  Densities for higher doses are more symmetric and flatter." /></p>
<div class="sourceCode" id="cb34"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb34-1"><a href="#cb34-1" tabindex="-1"></a>fullSummary <span class="sc">%&gt;%</span></span>
<span id="cb34-2"><a href="#cb34-2" tabindex="-1"></a>  <span class="fu">ggplot</span>(<span class="fu">aes</span>(<span class="at">x =</span> Dose)) <span class="sc">+</span></span>
<span id="cb34-3"><a href="#cb34-3" tabindex="-1"></a>  <span class="fu">geom_ribbon</span>(<span class="fu">aes</span>(<span class="at">ymin =</span> Q05, <span class="at">ymax =</span> Q95), <span class="at">fill =</span> <span class="st">&quot;steelblue&quot;</span>, <span class="at">alpha =</span> <span class="fl">0.25</span>) <span class="sc">+</span></span>
<span id="cb34-4"><a href="#cb34-4" tabindex="-1"></a>  <span class="fu">geom_ribbon</span>(<span class="fu">aes</span>(<span class="at">ymin =</span> Q10, <span class="at">ymax =</span> Q90), <span class="at">fill =</span> <span class="st">&quot;steelblue&quot;</span>, <span class="at">alpha =</span> <span class="fl">0.25</span>) <span class="sc">+</span></span>
<span id="cb34-5"><a href="#cb34-5" tabindex="-1"></a>  <span class="fu">geom_ribbon</span>(<span class="fu">aes</span>(<span class="at">ymin =</span> Q25, <span class="at">ymax =</span> Q75), <span class="at">fill =</span> <span class="st">&quot;steelblue&quot;</span>, <span class="at">alpha =</span> <span class="fl">0.25</span>) <span class="sc">+</span></span>
<span id="cb34-6"><a href="#cb34-6" tabindex="-1"></a>  <span class="fu">geom_line</span>(<span class="fu">aes</span>(<span class="at">y =</span> Mean), <span class="at">colour =</span> <span class="st">&quot;black&quot;</span>) <span class="sc">+</span></span>
<span id="cb34-7"><a href="#cb34-7" tabindex="-1"></a>  <span class="fu">geom_line</span>(<span class="fu">aes</span>(<span class="at">y =</span> Median), <span class="at">colour =</span> <span class="st">&quot;blue&quot;</span>) <span class="sc">+</span></span>
<span id="cb34-8"><a href="#cb34-8" tabindex="-1"></a>  <span class="fu">theme_light</span>() <span class="sc">+</span></span>
<span id="cb34-9"><a href="#cb34-9" tabindex="-1"></a>  <span class="fu">labs</span>(</span>
<span id="cb34-10"><a href="#cb34-10" tabindex="-1"></a>    <span class="at">title =</span> <span class="st">&quot;Posterior Dose toxicity curve&quot;</span>,</span>
<span id="cb34-11"><a href="#cb34-11" tabindex="-1"></a>    <span class="at">colour =</span> <span class="st">&quot;Dose&quot;</span>,</span>
<span id="cb34-12"><a href="#cb34-12" tabindex="-1"></a>    <span class="at">y =</span> <span class="st">&quot;P(Toxicity)&quot;</span></span>
<span id="cb34-13"><a href="#cb34-13" tabindex="-1"></a>  )</span>
<span id="cb34-14"><a href="#cb34-14" tabindex="-1"></a><span class="co">#&gt; Ignoring unknown labels:</span></span>
<span id="cb34-15"><a href="#cb34-15" tabindex="-1"></a><span class="co">#&gt; • colour : &quot;Dose&quot;</span></span></code></pre></div>
<p><img role="img" aria-label="A visual representation of the posterior dose - toxicity curve.  Very closely spaced solid lines in black and blue, representing the mean and median estimate of toxicity for each dose rise almost linearly from zero percent for a dose of zero to about 55% for a dose of 100.  Shading extends to each side of the two solid lines.  The transparency of the shading increases with distance from the solid lines.  The shading is funnel shaped, with a narrow mneck at a dose of 100 and a wider mouth at a dose of 100.  The shading represents the central 90%, 80% and 50% confidence intervals for the posterior mean estimate of toxicity at each dose." src="data:image/png;base64,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" alt="A visual representation of the posterior dose - toxicity curve.  Very closely spaced solid lines in black and blue, representing the mean and median estimate of toxicity for each dose rise almost linearly from zero percent for a dose of zero to about 55% for a dose of 100.  Shading extends to each side of the two solid lines.  The transparency of the shading increases with distance from the solid lines.  The shading is funnel shaped, with a narrow mneck at a dose of 100 and a wider mouth at a dose of 100.  The shading represents the central 90%, 80% and 50% confidence intervals for the posterior mean estimate of toxicity at each dose." /></p>
</div>
<div id="note" class="section level2">
<h2>Note</h2>
<p>The analyses presented in this vignette have used chains of a very
short length. This is purely for convenience. Analyses of real trials
should use considerably longer chains. As an example, an effective
sample size of approximately 40,000 is required to estimate a percentage
to within ±1%.</p>
</div>
<div id="references" class="section level2 unnumbered">
<h2 class="unnumbered">References</h2>
<div id="refs" class="references csl-bib-body hanging-indent" entry-spacing="0">
<div id="ref-Neuenschwander2008" class="csl-entry">
Neuenschwander, Beat, Michael Branson, and Thomas Gsponer. 2008.
<span>“<span class="nocase">Critical aspects of the Bayesian approach to
phase I cancer trials.</span>”</span> <em>Statistics in Medicine</em> 27
(13): 2420–39. <a href="https://onlinelibrary.wiley.com/doi/10.1002/sim.3230">https://onlinelibrary.wiley.com/doi/10.1002/sim.3230</a>.
</div>
</div>
</div>



<!-- code folding -->


<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
